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CHAPTER I INTRODUCTION 
Diseases, which are the result of immune reactions 
associated with tissue damage may be caused by several 
mechanisms. The immunologic mechanisms resulting in 
tissue damage have been categorized in 4 types (Gell and 
Coombs, 1968). 
1. the anaphylactic type, mediated by IgE type of anti-
bodies,resulting in immediate release of vasoactive 
arnines (e.g. histamine). 
2. the cytotoxic type, mediated by IgG and IgM type of 
antibodies and resulting in phagocytosis of the target 
cells or lysis by complement activation. 
3. the immune complex type, with either primary locali-
sation of the immune complexes in the tissues 
(Arthus reaction) or circulating immune complexes with 
secondary tissue localisation. 
4. the delayed type or cellular immune response mediated 
by thymus derived T-lymphocytes. 
In the studies to be reported, only diseases caused 
by the type 3 reaction, mediated by circulating immune 
complexes, are of concern. Examples of human diseases 
caused by the immune complex mediated type of tissue 
damage are a.o. serum sickness, systemic lupus erythema-
tosus (SLE) and several types of glomerulonephritis. 
The source of the antigens involved may be exogenous 
or endogenous; when endogenous, autoimmune diseases 
will be the result of such immune reactions. 
To monitor the activity of the immune complex media-
ted type of disease, it is of importance to dispose of 
techniques which are able to detect immune complexes in 
the circulation. 
In order to be of clinical interest, these techniques 
should meet the following requirements: 
1. The results of the test should correlate with clinical 
signs and symptoms of immune complex mediated disease, 
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i.e. the test should discriminate potentially pathogenic 
from "harmless" complexes. 
2. The test should include the possibility to detect the 
antigen involved in immune complex formation. 
3. Preferentially, the laboratory outfit needed should be 
relatively simple, and to perform the test, only commer-
cially available reagents should be necessary. An immune 
complex detection technique, which meets all these 
requirements, is not available. 
Tests to measure antigen-antibody interactions have 
been put into three categories.by Minden and Farr (1971): 
1. Tests based on the primary interaction between antigen 
and antibody. 
2. Secondary tests, which measure in vitro manifestations 
that may occur following primary interactions. 
3. Tertiary tests 1 based on in vivo manifestations of 
primary antigen-antibody interactions. 
These tests may be designed fo'r the detection and 
quantitation of known antigens or specific antibodies on 
one hand, on the other hand some techniques are designed 
for the detection of antigen-antibody complexes. 
Primary binding tests, designed for the quantitative 
measurement of antigen-antibody complexes are based on 
changes in physicochemical properties of antigens and 
antibodies after immune complex formation and include 
fractionated precipitation with ammonium sulphate (Farr, 
1958), analytical ultracentrifugation and gelfiltration 
techniques. 
Several secondary tests 1 which have been used for the 
detection of immune complexes are based on their inter-
action with the complement system. Since Agnello et al. 
(1970} described the agar gel precipitation technique 
with C1q globulin for demonstrating immune complexes, 
radiolabeled C1q has been used in combination with 
precipitation by polyethylene glycol {Nydegger et al. 
1974) and in a test based on the inhibition by immune 
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·complexes of the C1q uptake by sensitized erythrocytes 
(Sobel et al., 1975). 
An example of a tertiary test for the detection of 
immune complexes is the intradermal injection of serum in 
the skin of guinea pigs and to measure the immediate local 
inflammatory response (McAuliffe et al., 1973}. 
The fate of ci.rculating immune complexes is dependent 
on the type of the antigen, the antigen/antibody ratio and 
the immunoglobulin class and subclass of the antibody 
involved. Most antigen-antibody complexes are rapidly 
cleared from the circulation by phagocytosis by the 
reticula endothelial system, especially by the Kupffer 
cells in the liver (Benacerraf et al. 1959). On the other 
hand, the immune complexes may be deposited in renal 
glomeruli, vessel walls and other tissues, as has been 
confirmed in many studies of experimental and human 
disease since the classical experiments on the pathogenesis 
of serum sickness by Dixon et al. (1958}. 
Phagocytos.is of Ig and C by polymorphonuclear leuco-
cytes (PMN) has been demonstrated experimentally in vivo 
(Cochrane et al., 19591 and in vitro (Parker and Schmid, 
1962) and has also been observed in synovial fluid and 
peripheral blood from patients with rheumatoid arthritis 
and SLE (Rawson et al., 1965; Vaughan et al., 1968; Cats 
et al., 1975). In addition, Cats et al., (19751 reported 
in vitro phagocytosis by normal donor PMN of Ig and C 
from the sera of patients with rheumatoid arthritis and 
SLE. 
Therefore, evidence of phagocytized Ig and C in 
peripheral blood PMN might be an important parameter in 
monitoring diseases caused by circulating immune complexes. 
In this thesis some experiments and clinical, 
histological and IF studies are reported, which were 
designed with th.e purpose to develop a technique which 
enables to monitor diseases, mediated by circulating immune 
complexes. This technique is based on phagocytosis of 
ll 
immune complexes by FMN, both in vivo and in vitro. 
The studies included patients with SLE and hepatitis B, 
since SLE is one of the classical examples of an immune 
complex mediated disease (Cochrane and Koffler, 1973), 
and systemic manifestations in hepatitis B (e.g. arthritis, 
polyarteritis nodosa and glomerulonephritis) are also 
attributed to circulating immune complexes, presumably of 
HBsAg and anti HBs (Kohler, 1973; Gocke, 1975). In addition, 
the influence of the antigen-antibody ratio on the in 
vitro phagocytosis of artificially prepared HBsAg-anti HBs 
immune complexes was studied. 
12 
CHAPTER II 
In this chapter a technique is described for the isolation 
and IF-study of PMN, which facilitates the screening of 
large numbers of PMN obtained from relatively small 
volumes of blood. In addition, the results of IF-studies 
of PMN from the blood of nine patients with SLE in an 
active stage of the disease are reported. These results 
are compared with those obtained from matched normal 
controls and from seven patients with high levels of 
paraproteins. 
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SUMMARY 
Peripheral blood polymorphonuclear leucocytes (PMN) from patients with SLE 
in active stage were isolated and frozen in gelatin capsules. Sections cut from these 
frozen cell preparations were examined for the presence of inclusion bodies using 
the immunofluorescence technique. It was demonstrated that up to 80% of the poly-
morphonuclear cells contain small granular inclusions when tested with anti-lgG, 
-IgM, -IgA and antisera specific for several C components. Incidentally large homo-
geneous inclusions similar to the in vitro LE cell phenomenon were observed. PMN 
from normal controls matched for age, sex and race showed no inclusion bodies. 
Three out of six patients with paraproteinaemia of different Ig class had PMN in-
clusions consisting of the corresponding paraprotein only. These data suggest that 
inclusions in PMN from SLE patients are phagocytozed immune complexes. 
INTRODUCTION 
Since Parr in 1958 introduced fractionated globulin precipitation with ammonium sulphate 
for the detection of circulating immune complexes, many other techniques have been 
developed for this purpose, e.g. analytical ultracentrifugation, agar gel precipitation with 
Clq globulin and histamine release (reviewed by Cochrane & Kofiler, 1973). As it is known 
that antigen-antibody complexes are eliminated from the circulation by phagocytosis 
effected by the reticuloendothelial system (RES) and by deposition in renal glomeruli and 
other tissues (Benacerraf, Sebestijen & Cooper, 1959; Dixon et al., 1958, Orozco, Jasin & 
Ziff, 1970), the investigation of biopsy specimens of kidney and other tissues by means of 
immunofluorescence might also provide evidenGe for the presence of circulating immune 
complexes. For obvious reasons, however, frequent taking ofbiopsy specimens from patients 
is not admissible, which makes this method less suitable for followMup studies of immune 
complex disease in man. 
Phagocytosis of immune complexes by peripheral blood polymorphonuclear leucocytes 
(PMN) has been demonstrated experimentally in vivo (Cochrane, Weigle & Dixon, 1959) and 
in vitro (Parker & Schmid, 1962); the phenomenon has also been observed in rheumatoid 
synovia fluids (Rawson, Abelson & Hollander, 1965). Therefore, it is likely that PMN also 
Correspondence: J. W. Steffelaar, Department of Clinical Pathology, Medical Faculty of the Erasmus 
University, P.O. Box 1738, Rotterdam, the Netherlands. 
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contribute to the elimination of circulating antigen-antibody complexes. Although immuno-
globulin (Ig) inclusions in PMN have been noted in several diseases (Vaughan et al., 1968), 
the possible significance of this phenomenon as a parameter for the presence of circulating 
immune complexes has as yet not been studied. The purpose of the present study was to 
investigate, whether evidence for immune complex phagocytosis by PMN could be obtained, 
using the immunofluorescence technique. Since current knowledge points strongly towards 
circulating immune complexes as a pathogenetic factor in SLE (reviewed by Cochrane & 
Koffler, 1973), PMN from nine SLE patients in an active stage of the disease were studied. 
The results were correlated with those obtained by light microscopic and immunofluores-
cence studies of biopsy specimens from the same patients. 
MATERIALS AND METHODS 
Subjects. The study comprised nine patients-with SLE, as diagnosed according to the criteria proposed by 
the American Rheumatism Association (Cohen et al., 1971). All patients were in an active stage of the disease 
at the moment of blood sampling. From eight out of these nine patients renal, liver or skin biopsy specimens 
were available for examination with light microscopy and from six out of these eight patients such biopsy 
spe~imens were also available for immunofluorescence studies. 
Normal controls consisted of nine race-, age- and sex-matched individuals with no personal history of 
al!ergic disorders or recent bacterial and viral infections. In addition, seven patients with hypergamma-
globulinaemia, unrelated to SLE were included as controls. Three of these patients had an IgG paraprotein-
aemia with an IgG level of 250, 280 and 840 i.u./ml respectively, two had an IgA paraproteinaemia with 
an IgA level of 3680 and 6840 i.u.(ml respectively, one had an IgM paraproteinaemia with a level of 7552 
i.u./ml and one an IgE level of 28,000 i.u./ml. 
Polymorphonuclear leucocytes. PMN were isolated according to BOyum (1968) with a slight modification: 
to each of two tubes containing tO ml of fresh, defibrinated venous blood 2·5 ml of 5% dextran in 0·9% saline 
(molecular weight 200,000) (Poviet, Amsterdam, the Netherlands) were added. Red blood cells (RBC) were 
allowed to sediment at 37"C for 30 min. Each supernatant was diluted with one volume of minimal essential 
medium (MEM) (Gibco, Grand Island, New York) containing 25 mM Tris (pH 7-4) at 20°C and layered on 
top of 3 ml Ficoll-Isopaque mixture of specific gravity 1·077 present in each of two tubes with a diameter of 
14mm. 
After centrifugation at 20°C for 40 min at 400 g the interphase, containing mononuclear cells, was carefully 
aspirated and the medium and Ficoll-Isopaque mixture were discarded. To the pellet 3 ml of an ice-cold 
isotonic NH4Cl solution containing 0·155 M NH4Cl, 10 mM KHC03 and 0·1 mM EDT A (pH 7·4) were added 
to resuspend the pellet and to accomplish lysis of -contaminating RBC (Roos & Loos, 1970). To achieve this 
the tubes were kept at ooc for 5 min under constant stirring. After that the tubes were filled with washing 
fluid as described by Hijmans, Schuit & Klein (1969) and centrifuged for 10 min at 90 g. The pellet was 
resuspended in ten drops of washing fluid and fixed for 5 min by adding ten drops of a 2/o paraformaldehyde 
solution in phosphate-buffered saline, 0·01 M, pH 7·8 (PBS) as previously described (Smit eta!., 1974). After 
centrifugation for 10 min at 90 g the supernatant was removed and the pellet washed twice by resuspension in 
10 ml washing fluid and subsequently centrifuged again. The PMN were finally suspended in five to seven 
drops of 5% gelatin in washing fluid, counted in a Bilrker chamber and frozen in a gelatin capsule in liquid 
nitrogen as described earlier for minute tissue specimens (Feltkamp-Vroom & Boode, 1970). The cellular 
concentration ranged from 6 to 10 x 106 PMN/ml, contamination with RBC or platelets was negligible. 
Differential counts generally showed 1-3% mononuclear cells. 
Immunofluorescence procedure for PMN. The indirect immunofluorescence technique was used for the 
demonstration ofigG, IgG1, IgG2, IgG3, lgG4, IgM, IgA, Clq, C3B, C3c, C3d and C4. Cryostat sections of 
4 pm were cut from the frozen gelatin capsules, airdried for 30 min and washed for 30 min with PBS. Then 
the sections were incubated for 30 min at room temperature with the specific rabbit anti-human antisera.All 
antisera were prepared in the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service 
and tested for specificity by immunoelectrophoresis, gel double diffusion and the tanned red cell haemagglu-
tination technique. As second layer horse anti-rabbit immunoglobulin serum conjugated to fiuorescein-iso-
thiocyanate (FITC) (The & Feltkamp, 1970), was used. The presence ofigE was studied in the direct technique 
using a FITC labelled anti-polyclonal IgE serum, as described previously (Feltkamp-Vroom et al., 1975). 
Sections incubated with normal rabbit serum as first layer as well as sections incubated with the conjugated 
horse anti-rabbit serum only were used as negative controls. 
Nuclear counterstainingwas performed by incubating the sections with ethidium bromide (0·02 mg/ml in 
PBS, Calbiochem, Santiago, California) for 2 min (Udenfriend, 1969). 
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ofig, and C components in the glomerular capillary walls except for that of patient 7 (Table 
1), which demonstrated slight proliferative glomerular changes only. The one liver biopsy 
specimen available (patient 5, Table 1), showed massive cytoplasmic fluorescence ofKupffer 
cells for IgG, IgM, IgA and C components. None of the tissues showed IgE in granular 
deposits or Kupffer cells. 
DISCUSSION 
Freezing of PMN suspensions in gelatin capsules and subsequent cutting of 4 .urn sections in 
a cryostat proved to be a useful technique in order to obtain preparations that are suitable 
for immunofluorescence studies of these cells. The main advantages of this technique are 
that firstly a large number of sections can be cut from a rather small sample and that second-
ly sections can be cut at any desired moment after preparation of the frozen suspensions. By 
fixation in I% paraformaldehyde prior to freezing the cells are well preserved, while sig-
nificant alteration of antigens does not occur (Smit et a!., 1974). Nuclear counterstaining 
with ethidium bromide allows easy identification of the nuclei (Udenfriend, 1969), using the 
same excitation light as for FITC fluorescence. This quick and simple method has proved to 
be very useful for determining the number of cells that do not show FITC fluorescence. 
With the immunofluorescence procedure described in this paper we could demonstrate 
that PMN isolated from venous blood of SLE patients contain cytoplasmic inclusions con-
sisting of lgG, lgM and IgA as weB as of the complement components C1q, C3c, C3d and 
C4. It is not surprising that no inclusions with IgE were found, since in a previous study it 
could be established that IgE cannot be found in immune complex deposits (Feltkamp-
Vroom eta/., 1975). The failure to demonstrate C3B, the conformation determinant of C3, is 
just a matter of course since this determinant rapidly disappears after activation of C3 
(Molenaar eta/., 1974). 
This PMN inclusion phenomenon may represent either phagocytized Ig aggregates or 
immune complexes. Although it is not possible to exclude the presence of Ig aggregates 
some of our observations are in favour of immune complex phagocytosis. If aggregates 
of Ig and subsequent phagocytosis occur in SLE patients, our findings do not suggest that 
this is caused by changes in the concentration of Ig in their serum, since PMN from normal 
controls with only slightly lower lg levels did not show inclusions. Moreover, only three out 
of the six patients with moderately to extremely high serum levels of paraproteins showed 
PMN with cytoplasmic inclusions, and those who reacted positively did so rather weakly, 
since the number of PMN with inclusions only positive for the corresponding Ig class of the 
paraprotein, was very low. Although this finding may be the result of paraprotein aggrega-
tion with subsequent phagocytosis, it is not likely that the same mechanism accounts for the 
large quantities of Ig of several classes together with C ingested by PMN as observed in our 
SLE patients. Furthermore, the granular deposition oflg and C components in the glomeru-
lar capillary walls of all kidney biopsy specimens available except for one are suggestive for 
the presence of circulating immune complexes. Moreover, the many Kupffer cells in the one 
liver biopsy specimen showing massive cytoplasmic fluorescence of Ig and C indicate that 
also in man Kupffer cells play an important role in the elimination of circulating immune 
complexes as has been demonstrated in mice, rabbits and monkeys (Benacerraf eta!., 1959; 
Mannik & Arend, 1971). 
Many reports have provided data, that are suggestive for DNA-anti-DNA complexes 
being responsible for glomerular lesions in SLE (Koffler, Agnello & Kunkel, 1974; Koffler, 
Schur & Kunkel, 1967; Robitaille & Tan, 1973). However, our studies are not suggestive for 
the presence of DNA in the phagocytozed material seen as small inclusions.. 
In· view of their size and localization these inclusions may be phagolysosomes and may 
contain deoxyribonuclease (Cohn & Hirsch, 1960). Should this hypothesis be true the 
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deoxyribonuclease will digest DNA, which makes the detection of DNA, if present as the 
antigen of immune complexes in SLE, when phagocytozed by PMN of SLE patients, im-
possible. In the large homogeneous inclusion bodies we, however, were able to demonstrate 
DNA. Considering the similarity of these inclusions to those found in the LE-cell pheno-
menon, we suppose that the large homogeneous inclusion bodies consist of phagocytozed 
nuclear material. The large amount of this material in which DNA has been found, leads 
probably to its detection as it cannot be broken down in a short lapse of time. Since in vitro 
studies of the catabolism of bovine serum albumin (BSA) and antibody by rabbit PMN after 
phagocytosis of BSA-anti-BSA complexes have demonstrated that up to 46% of the 
amount of antigen that was originally present was broken down within 24 hr (Cochrane 
et al., 1959) and since in vivo studies on circulating PMN indicate that the whole population 
is replaced about two and a halftimes within 24 hr (Boggs, 1967), the-observation ofPMN 
with immunoglobulin and C inclusions, points to a very active and continuous phagocytosis 
in SLE patients. Therefore, immunofluorescence studies on PMN might provide an impor-
tant parameter for the determination of the activity of the disease and of the effect of therapy. 
In follow-up studies PMN inclusions will have to be studied in relation to the presence of 
circulating immune complexes as demonstrated by direct methods, as well as in relation to 
serological findings and clinical parameters. The impaired in vitro phagocytosis by PMN 
from SLE patients, which has been reported (Brandt & Hedberg, 1969; Oroczo et al., 1970), 
is another point that remains to be elucidated. Our findings suggest that this impairment is 
due to phagocytosis by PMN prior to the in vitro test. 
ADDENDUM 
Following submission of this manuscript it was found that similar studies on granulocytes 
isolated from heparinized blood of SLE patients contain less and smaller granules than 
those isolated from defibrinated blood. Therefore it is likely that during the defibrination 
procedure with glass beads granulocytes still phagocytoze immune complexes and nuclear 
material bound to ANF. 
The authors are grateful to Dr Marijke van der Giessen and co-workers for the production of the antisera, to 
Dr C. P. E. Engelfriet and co-workers for the specificity testing of the antisera by haemagglutination, to Dr 
Eveliene E. Reerink-Brongers and co-workers for the Ig determinations, Mrs Ellen Hertroijs and Mrs Irma 
Moerkerken-Mersel for secretarial help and Mrs Anneke Knappers for assistance in preparing the manu-
script. 
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In this chapter a study of the influence of several 
anticoagulants, used for PMN isolation, on the occurrence 
of cytoplasmic Ig and C inclusions in these cells is 
reported. In addition, the influence of the antigen-
antibody ratio on the in vitro phagocytosis of immune 
complexes was studied. For this purpose, immune complexes 
prepared from human HBsAg containing serum and human anti 
HBs containing serum were used. 
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SUH1.1ARY 
Polymorphonuclear leucocytes (PMN) from patients with 
systemic lupus erythematosus (SLE) were isolated from 
defibrinated and heparinized blood. In addition, PHN from 
a healthy donor were incubated with sera from SLE patients 
and with sera containing artificially prepared immune 
complexes of hepatitis B surface antigen (HBsAg) and human 
anti-HBsAg immunoglobulin (anti-HBs) with well defined 
variations of the antigen/antibody ratio. To one group of 
blood samples, 5 mM monoiodine acetic acid (MIAA) was 
added to block in vitro phagocytosis. 
The PHN were examined for the presence of IgG, Ig.M, 
and HBsAg by the immunofluorescence technique. PMN from 
defibrinated blood of SLE patients showed in up to 80% 
immunoglobulin (Ig}-inclusions. However, addition of 5 ~~ 
MIAA reduced the number of Ig-containing PMN to at most 
40%, which levels were equal to numbers found in specimens 
from heparinized blood. Addition of 5 mM MIAA to 
heparinized blood did not reduce the number of PMN with 
Ig inclusions. Normal donor PMN isolated from defibrinated 
heparinized, and EDTA blood showed equal amounts of Ig 
inclusions after incubation with SLE sera, but none when 
MIAA had been added. In PMN incubated with HBsAg-anti HBs 
immune complexes with an antigen antibody ratio between 
5 and 0.2, both HBsAg and IgG could be detected. 
It is concluded that Ig inclusions in PMN from 
heparinized blood from SLE patients are due to in vivo 
phagocytosis, presumably of circulating immune complexes. 
In vitro phagocytosis of Ig from SLE sera by normal donor 
Pt1N also suggests the presence of immune complexes. 
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Dependent o"n the antigen-antibody ratio, artificial 
HBsAg/anti HBs immune complexes can be detected by in 
vitro phagocytosis by PMN. 
INTRODUCTION 
Immunofluorescence studies in polymorphonuclear 
leucocytes {PMN) isolated from venous blood of patients 
with systemic lupus erythematosus (SLE), have demonstrated 
cytoplasmic inclusions composed of immunoglobulins (Ig) 
and complement components {C) presumably indicating immune 
complex phagocytosis (Vaughan et al. 1968; Cats, Lafeber 
and Klein 1975; Steffelaar, de Graaff-Reitsma and 
Feltkamp-Vroom 1976). However, PMN isolated from 
heparinized blood from SLE patients showed fewer and 
smaller inclusions than PMN isolated from defibrinated 
blood of the same patients (Steffelaar et al. 1976). 
Therefore, some of the inclusions in the PMN from 
defibrinated blood might represent in vitro phagocytosis 
of artificial immune complexes, possibly originating from 
cellular destruction by defibrination in the presence of 
anti nuclear antibodies (ANA) . 
The finding of in vitro phagocytosis by normal donor 
PMN of Ig and C from the sera of patients with rheumato'id 
arthritis and SLE (Cats et al. 1975) suggests that not 
all inclusions are caused by artificial immune complexes. 
The use of the in vitro technique and incubation of normal 
donor PMN with the sera to be tested for the presence of 
immune complexes, facilitates the study of factors with an 
influence in immune complex phagocytosis by PMN. The 
purpose of the present study was to find out whether immune 
complex phagocytosis occurs: 1. in vivo by peripheral 
blood PMN, studied in SLE patients (direct test), and 2. 
in vitro by normal donor PMN incubated with SLE sera 
(indirect test) as detected by the immunofluorescence 
technique. In addition, the influence of the antigen/ 
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antibody ratio on the in vitro phagocytosis of arti-
ficially prepared immune complexes was studied. 
Because of the possible pathogenetic role of immune 
complexes in glomerulonephritis, arthritis and vasculitis, 
described in association with human hepatitis B {Combes 
et al. 1971; Myers et al. 1972; Wands et al. 1975; 
Sergent et al. 1976), immune complexes, prepared from 
human serum containing hepatitis B surface antigen {HBsAg) 
and human anti-HBsAg immunoglobulin (anti-HBs) containing 
serum were used for this purpose. 
MATERIALS AND METHODS 
Subjects 
The study was done in five patients with SLE 
diagnosed according to the criteria proposed by the 
American Rheumatism Association (Cohen et al. 1971). 
All five were in an active stage of the disease when the 
blood was sampled. PMN were isolated from this blood as 
described below (direct test) , and the sera were used for 
the study of in vitro phagocytosis by normal donor P~1N 
(indirect test). PMN for the in vitro studies were 
isolated from a healthy donor (bloodgroup 0) with negative 
serological tests for HBsAg and anti-HBs. 
Polymorphonuclear leucocytes 
PHN were isolated with a slight modification of the 
technique described previously (Steffelaar et al. 1976): 
10 ml of blood was either defibrinated, by shaking gently 
with glass beads for 10 min; heparinized (Thromboliquine, 
Organon, Oss, the Netherlands) or decalcified by addition 
of 6 mM EDTA. Blood samples were also heparinized and 
subsequently shaken with glass beads like the defibrinated 
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samples. One half of each blood sample was collected in 
5 m.~ MIAA (pH 7. 2) in order to b.lock in vitro phagocytosis. 
After sedimentation with dextran (molecular weight 200,000) 
(Poviet, Amsterdam, the Netherlands) at 37oC for 30 min, 
the supernatant was layered on top of 1.5 rnl Lymphoprep 
(Nyegaard, Oslo, Norway). After centrifugation at 20oC 
for 40 min at 400 g, the supernatant was discarded and the 
pellet was washed once by resuspension in washing fluid as 
described by Hijmans, Schuit and Klein (1969) and centri-
fuged for 10 min at 90 g. The recovery of PMN from 
heparinized blood was at least 95%. From the samples 
shaken with glass beads, about 20 per cent fewer Pr-1N were 
harvested. 
The PMN from the SLE patients were fixed, washed 
twice and frozen in a gelatin capsule in liquid nitrogen 
as described elsewhere (Steffelaar et al. 1976). 
Phagocytosis in vitro. 
a. After PMN isolation from donor blood (indirect test A) 
After Lyrnphoprep-centrifugation, the pellets (each 
obtained from 5 ml of donor blood) were washed by 
resuspension in 5 ml of washing fluid and centrifugation 
for 10 min at 90 g. The pellets were then resuspended in 
12 drops of washing fluid and 10 drops of the sera to be 
tested were added as well as 2 drops of the donor serum. 
After incubation at 37oC for 20 min, the suspensions were 
centrifuged for 10 min at 90 g and the pellets were washed, 
fixed 1 and frozen as described for the patient PMN. 
b. Before PMN isolation from donor blood (indirect test B) 
Three ml of donor blood were collected in 1.5 ml of 
SLE-serum to which heparin, glass beads or both had been 
added. The samples containing glass beads were gently 
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shaken for 10 min. From these blood-serum samples PMN 
were isolated, fixed and frozen as described above. 
ANA-Titres 
The ANA-titres were determined in the SLE-sera by the 
immunofluorescence technique. Cryostat sections of normal 
rat liver tissue were incubated with several dilutions of 
the sera, followed by washing in PBS (pH 7.2) and sub-
sequent incubation with FITC-labeled horse-anti-human 
immunoglobulin (Central Laboratory of the Netherlands Red 
Cross Blood Transfusion Service, Amsterdam, the Nether-
lands). After isolation of PMN, the ANA-titres, corrected 
for a dilution factor caused by the PMN isolation proce-
dure, were also determined in the remaining serum and 
plasma samples of the SLE-patients. 
Preparation of artificial immune complexes. 
HBsAg containing serum was obtained from a patient 
with hepatitis B. The HBsAg titre was 1:6,400, determined 
with the haernagglutination inhib~tion technique (Reesink, 
Duimel and Brurnmelhuis, 1973). Anti-HBs containing serum 
was collected from a reconvalescent hepatitis B patient. 
In the haemagglutination technique (Reesink et al. 1973) 
the anti-HBs titre was 1:51,200. 
The equivalence ratio of this HBsAg/anti-HBs serum 
pair was determined by mixing them in different ~ropor­
tions and applying the agar gel diffusion test with HBsAg 
and anti-HBs. The equivalence ratio was defined as the 
HBsAgjanti-HBs ratio for which the sample reacted with 
neither HBsAg nor anti-HBs. The equivalence ratio was 
said to be 1, and was used as the reference point to 
obtain immune complexes with HBsAg/anti-HBs ratios ranging 
from 10 to 0.01. The antigen excess immune complexes were 
prepared by adding HBsAg containing serum to a constant 
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amount of anti HBs containing serum. The antibody excess 
immune complexes were prepared by adding anti HBs to a 
constant amount of HBsAg containing serum. The sera were 
rapidly mixed, followed by an incubation period of two 
hours at room temperature. 
Immunofluorescence procedure 
The indirect immunofluorescence technique was used 
for the demonstration of IgG and IgM and the number of 
cells with fluorescent inclusions were counted as pre-
viously described {Steffelaar et al. 1976). The presence 
of HBsAg was determined with the direct technique, using 
rabbit-anti-HBsAg antiserum (Roes, Feltkamp-Vroom and 
Helder 1976) conjugated to fluorescein isothiocyanate 
{FITC) {The and Feltkamp 1970) and adsorbed with sonifi-
cated donor PMN. 
RESULTS 
Direyt and indirect tests in SLE patients 
Immunofluorescence studies revealed two types of 
PMN-inclusions containing IgG or IgM: small granular 
inclusions and occasional large (7-12 mu) homogeneous 
inclusion bodies as described elsewhere (Steffelaar et al. 
1976). The large inclusions were only present in Pr·1N from 
either defibrinated blood samples or heparinized samples 
to which glass beads had been added, both in the direct 
test and in de indirect test B, but not in de indirect 
test A. However, in the samples containing MIAA, no large 
inclusions could be detected. 
Table 1 shows the percentages of PMN with small 
granular inclusions containing IgG or Ig!'-1 for the SLE 
patients (direct test and indirect test A) . 
In the indirect test B the percentage of PMN with 
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Table l 
Percentage of PMN showing small granular Ig-inclusions in the direct test and indirect 
test A for five SLE patients 
Patient 1 2 3 4 5 
Inclusions IgG IgM Ig::; IgM IgG IgH IgG Ig"l IgG IgM 
~~- ~~- ~~- ~~- ~~- ~~- ~~- ~-
5 m!-:1 MIAA ~ D I D I D I D I D I D I D I D I D I D I 
Defibrination - 40 5 30 10 80 20 70 20 50 10 40 10 5 0 40 15 80 10 70 20 
+ 5 0 10 0 40 0 30 0 10 0 15 0 0 0 20 0 20 0 20 0 
Heparin - 5 5 10 10 40 20 30 20 10 10 15 10 0 0 20 15 20 10 20 20 
+ 5 0 10 0 40 0 30 0 10 0 15 0 0 0 20 0 20 0 20 0 
EDTA - - 5 - 10 - 20 - 20 - 10 - 10 - 0 - 15 - 10 - 20 
+ - 0 - 0 - 0 - 0 - 0 - 0 - 0 - 0 - 0 - 0 
D 
' 
I = direct test or indirect test A. 
"' 
"' 
granular Ig-containing inclusions were the same as in 
the indirect test A, when the PMN were isolated from 
heparinized blood. However, when isolated from defibrina-
ted blood, or when glass beads were added to heparinized 
samples with subsequent shaking, the percentages rose to 
60-80% in all cases. The donor PMN contained no inclusions 
in the direct test, or in the indirect test when incubated 
with either SLE serum in the presence of 1·1IAA or with 
normal human serum. 
ANA-Titres 
All SLE-patients showed ANA-titres varying from 
32 to 128. No significant reduction in the ANA-titres was 
demonstrated after defibrination and subsequent PMN-
isolation. However, the samples containing heparin showed 
a marked reduction of the ANA-titres. 
Phagocytosis of artificially prepared immune complexes 
Pr>l:N incubated with HBsAg/anti HBs im.-nune complexes 
with an antigen/antibody ratio ranging from 5 to 0.2 
showed inclusions composed of both HBsAg and Ig, as 
Table 2 shows. The number and size of the inclusions were 
arbitrarily scored as +, ++ or +++. However, neither HBsAg 
nor Ig was detected in the P_MN when the antigen/antibody 
ratio of the immune complexes was 8 or more, and only Ig 
was demonstrated when this ratio ranged from 0.1 to 0.01. 
DISCUSSION 
The results of immunofluorescence studies on PHN 
isolated from the blood of SLE patients (direct test) are 
dependent on the isolation procedure used. When isolated 
from defibrinated blood 1 up to 80% of the PHN show small 
granular inclusions composed of immunoglobulins of several 
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Table 2 
In vitro phagocytosis of HBsAg-anti HBs immune complexes 
and variation in the Ag/Ab ratio. 
Ratio 
HBsAg I anti-HBs 
10 
8 
5 
3 
2 
1 
0.5 
0.33 
0.2 
0. 1 
0.05 
0.02 
0.01 
Controls 
HBsAg 
anti HBs 
NHS" 
normal human serum 
Immunofluorescence 
Fl0 ) 
RaHBsAg 
+ 
+ 
++ 
++ 
+++ 
++ 
+ 
+) 
a IgG 
a Igr-1 
+ 
+ 
++ 
++ 
+++ 
+++ 
+++ 
++ 
++ 
+ 
+ 
" NHS 
o) 
+) 
rabbit anti HBsAg antiserum conjugated to FITC 
rabbit anti human IgG and rabbit anti human Ig~1 
antisera 
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conditions of slight antibody excess. 
To our knowledge there are no published reports con-
cerning the pathogenic properties of HBsAg/anti HBs immune 
complexes in relation to their antigen/antibody ratio. 
However, the relative quantities of antigen and antibody 
have been demonstrated under many experimental conditions 
to be of crucial importance for the pathogenecity of the 
resulting immune complexes. In both the one shot serum 
sickness model and experimental chronic serum sickness 
slight antigen excess results in the formation of patho-
genic immune complexes causing glomerular and vascular 
lesions (Dixon et al. 1958, 1971). Viral infections may 
correspond with this experimental situation, and persis-
tent viremia, which induces a low-level continuous immune 
response resulting in glomerulonephritis, has been 
reported in the course of chronic viral infections in 
various animals (Oldstone and Dixon 1971). 
Glomerulonephritis (Combes et al. 1971; ~1yers et al. 
1972; Knieser et al. 1974; Kohler et al. 1974), arthritis 
(Wands et al. 1975), and vasculitis (Sergent et al. 1976) 
have also been described in human hepatitis B patients, 
and are presumably due to immune complex deposition. 
It may be postulated that in human hepatitis B too; 
approximate balance of the HBsAg and anti HBs production 
results in pathogenic immune complexes. several authors 
have reported the demonstration of HBsAg-anti HBs immune 
complexes in serum from hepatitis B patients (Shulman and 
Barker, 1969; Nydegger et al. 1974; Wands et al. 1975; 
Theofilopoulos, Wilson and Dixon, 1976), but others failed 
to detect such complexes (Sergent et al. 1976). 
The results reported here indicate that complexes 
formed under conditions of approximate balance of HBsAg 
and anti HBs are readily demonstrated on the basis of in 
vitro phagocytosis by PMN. Since these complexes are 
likely to be pathogenic when occurring in vivo 1 it would 
be worthwhile to find out whether HBsAg and Ig inclusions 
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can be demonstrated in peripheral-blood PMN of hepatitis B 
patients with signs and symptoms of arthritis, vasculitis, 
or glomerulonephritis. 
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CHAPTER IV 
HBsAg AND SYSTEMIC DISEASE. REVIEW OF THE LITERATURE. 
INTRODUCTION 
Several studies (Kohler 1 1973; Gocke, 1975) have 
drawn attention to extrahepatic manifestations of viral 
hepatitis and the .role of circulating immune complexes 
in the pathoqenesis of these syndromes. Gocke {1975) 
rPcognized three types of syndromes: first a se~urn sickness 
like prodrome of acute hepatitis consisting of urticaria, 
rashr polyarthralgia and sometimes arthritis. Secondly he 
noted an incidence of 30-40% of HBsAg antigenaernia in 
patients with PAN, and thirdly, an immune complex type of 
glornerulonephri tis, usually i.n association with chronic 
active hepatitis. 
In this chapter, the literature concerning systemic 
manifestations of hepatitis B is reviewed, as well as 
the techniques used for detection of circulating HBsAg-
anti HBs immune complexes. 
HBsAg AND VASCULITIS 
A high incidence of HBsAg has bee!.l demonstrated in 
-r.he serum of patients with PAN (Prince and Trepo, 1971; 
Gocke et al., 1971; Trepo, Zuckerman and Prince, 1974}. 
However, the role of HBsAg-anti HBs immune complexes in 
the pathogenesis cf vasculitis is still controversial. 
Gocke et al. (1971) demonstrated both HBsAq and Ig 
in vessel walls by the IFT in two out of six patients 
t.,ith combined PAN and HBsAg-positive serology. In these 
two patients and in one patient without HBsAg or Ig in 
affected vessel w2lls, evidence of circulating immune 
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complexes was obtained by lowered CHSO-vnlues and by the 
C1q-precipitation reaction as described by Agnello, 
Winchester and Kunkel (1970). In the same study, in the 
five patients ~ested,20 and 40 nm particles were demon-
strated bv electL·on :nicroscopic examinatj.on of serum 
pellets after ultracentrifugation. These particles were 
interpreted as characteristically associated with HBsAg. 
However, t-.he pellets were negative by immunologic 
techniques for HBsAg, ?.nd aggregation of the particles, 
indicative of immune complex formation (Almeida and 
Waterson, 19691 was not reported. 
Prine~ and Trepo (1971} rep0rted 4 HBsAg seropositive 
c~ses out of 15 patients with PAN. Three more patients 
h3.d detectable anti HBs. No IF-studies were reported or:-
thP biopsy specimens. In one out of four serum specimens 
from the HBsAg sernpositive patients with PAN immune 
complexes t;Jere demonstrated by density gradient centrifu-
qation. The authors conclnded that the existen.ce of these 
complexes might be an epiphPnomenon unrelated to the 
primary pathogenetic mechanism. 
Heathcote, Dudley and Sherlock (1972) reported five HBsAg 
seropositive patients with chronic hepatitis and PAN. 
In this study no complexes of HBsAg and antibody in the 
sera wer2 seP.n with the electron microscope and no such 
complexes were seen in the affected vessel walls by IF. 
However, low serum levels of C4, anticomplementary activi-
ty of the sera from two patients and Ig- and c- deposits 
in vessel walls in two patients suggested that immune 
complexes apparently not containing HBsAg were involved LLJ. 
the pathogenesis of the vasculitis in these patients. 
Gerber et al. (1972) reno.rted a patient with lymphatic 
leucaemia, who developed active PAN one month after 
recovery of an acute hepatitis B. No circulating immune 
complexes were detected in the serum neither with the use 
of the C1q precipitation technique (Agnello et al. 1970), 
nor by electron microscopic examination of serum 
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pellets after ultracentrifugation. IF-studies of art2ries 
with PAN demonstrated HBsAg in the lesions, without the 
presence of Ig or C. Since HBsAg was also present in renal 
infarctions, the authors suqgested that these deposits 
might be secondary to tissue dnmage. 
Baker et al. {1972) reported one patient with PAN 
subsequent to HBsAg positive hepatitis. IF-studies showed 
HBsAg in the walls of the affected vessels; however, Ig 
or C were not demonstrated. Serum complement levels were 
normal. Electron microscopic examination of serum pellets 
showed 20 nm particles as described in association with 
HBsAg. Clumping of these particles was not demonstrated. 
Kohler {1973) reported the presence of HBsAg in the 
serum of one patient with PAN and anti-HBs in another 
in a series of 7 consecutive cases of PAN. In IF-studies 
of autopsy tissue of two cases, no HBsAg could be demon-
strated in the vessel walls. 
Trepo et al. {1974) reported serological studies on 
55 cases of PAN. Histological data and IF-studie~ of the 
affected vessels were not reported. HBsAg was detected in 
30 patients and anti-HBs in 13 patients. In 5 out of these 
cases both HBsAg and anti-HBs were present. In one of four 
cases from this series lowered complement levels and 
raised anticomplementary activity was reported. Electron 
microscopic detection of clumps of HBsAg-associated parti-
clP.s iD serum pellets were considered to represent circu-
lating immune complexes, and were demonstrated in 12 out 
of 18 cases with active vasculitis. No clumping was 
demonstrated in two cases with quiescent vasculitis. 
The authors concluded that circulating HBsAg-anti HBs 
complexes might be responsible for PAN. However, no 
correlation was found between the presence of immune 
complexes and the type of t~e hepatitis. 
Sergent et al. {1976) reported HBsAg-positive sero-
logy in nine out of 21 patients with PAN. Four cases were 
presented in an earlier report {Gocke et al .• 1970). 
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Except for one renal biopsy specimen without signs 
of PAN, no IF-studies on biopsy specimens were reported. 
In 3 cases serum complement levels were determined during 
active vasculitis and found to be less than 30% in one. 
In sera from 5 cases obtained during active periods of 
vasculitis immune complexes could not be demonstrated by 
the C1q precipitation reaction (Agnello ct al., 1970) nor 
by double diffusion in gel against purified IgM rheumatoid 
factor (Winchester et al., 1971) Also ultracentrifugation 
studies using 125 r-HBsAg added to patients sera failed to 
demonstrate immune complexes, and none of the patients 
showed cryoglobulinaemia. 
Histologic data concerning liver disease in hepatitis 
B patients with associated PAN, summarized in table 1 1 
were presented by Trepo, Thivolet and Lambert (1972) 
(2 cases}, Heathcote et al. (5 cases), Nowoslawski et al. 
(6 cases), Gerber et al. (1 case) 1 Baker et al. (1 case), 
Sergent et al. (9 cases) and Duffy et al. (10 cases). 
These data indicate that no significant relation of PAN 
to any of the histological types of hepatitis can be 
recognized. 
HBsAg AND ARTHRITIS 
The incidence of joint manifestations in viral 
hepatitis 1 as given by several authors varies from 1.6% 
to 49% 1 according to the manner in which it '.·:as sought 
(reviewed by Alarcon and Townes, 1973). In 20.6% of 
patients with hepatitis a history of arthralgia could be 
elicited aftP.r specifically asking for it (Mosley and 
Galambos, 1969). However, Alarcon and Townes (1973) 
collected only 57 cases with objective signs of arthritis 
(i.e. redness, swelling or increased local temperature) 
from an extensive study of the literature, including their 
own 5 cases. In all cases it was characterized as a self~ 
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Table l 
Histological diagnoses on liver biopsy specimens from 
hepatitis B patients with associated PAN, compiled 
from the literature (see text). 
Diagnosis No. of cases 
AcH 6 
CPH 8 
CAH 7 
Cirrhosis 2 
Aspecific 5 
"Hild hepatitis" 2 
"Moderate hepatitis" l 
"Subacute hepatitis" l 
"Fulminant hepatitis 11 l 
Septal fibrosis l 
Total 34 
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limiting disease of about three weeks duration. 
Kohler (1973) reported an ovP-rall incidence of 29% of 
immune complex symptoms in 100 cases of acute hepatitis B 
and noted that these symptoms occurred significantly more 
frequently in female compared to male patients (48% and 15% 
respectively). The symptoms included arthralgia-arthritis 
and urticaria-rash, and occurred predominantly during the 
prodromal phase of hepatitis. No vasculitis or glomerulo-
nephritis was reported in this series. 
Support for the hypothesis that circulating imc•mne 
complexes are a major pathogenetic factor in serum 
hepatitis-associated arthritis was first derived from 
complement component studies (Alpert, Isselb~chRr and 
Schur, 1971; Onton, Cn.unpacker and Gilliland, 1971). 
Alpert et al. (1971) reported low serum levels of CHSO, 
C4 and C3 in eight out of nine patients with active 
arthritis, in association with high titres of HBsAg.In 
contrast to these findings in patients with acute joint 
symptoms, normal or elevated complement component levP-ls 
were demonstrated in patients during convalescence from 
these symptoms or without signs of arthritis. No anti-HBs 
was detected in any of the patients with and without 
arthritis. Sequential studies of serum complement levels 
in the course of HBsAg-related arthritis have been reported 
and were interpreted as additional evidence of the role of 
circulating immune complexes in this disease (Onion et al., 
1971; Wenzel et al., 1972; Alpert, Schur and Isselbacher, 
1972). However, normal serum complement levels during the 
acute phase of hepatitis-associated arthritis have also 
been reported (Alpert et al., 1971; McCarty and Ormiste, 
1973; Duffy et al., 1976) in 20 out of 42 cases. 
Wands et al.(1975) analyzed the occurrence and 
composition of cryoprecipitable proteins in 6 patients 
with acute HBsAg-positive hepatitis, in three cases 
complicated by arthritis. In most sera the antigen titer 
was raised several fold in the cryoprecipitate as compared 
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to whole serum titres. In one case complicated by arthritis 
the simultaneous occurrence of HBsAg and anti HBs was 
demonstrated in low titres in the cryoprecipitate, whereas 
in whole serum a high titre of antigen was demonstrated 
without detectable antibody. Both HBsAg and anti HBs 
disappeared from cryoprecipitate and whole serum as the 
arthritic symptoms subsided. Sequential studies revealed 
the successive occurrence of antigen and antibody in the 
expected order in two cases; in two cases only antigen 
was demonstrated and in one case only antibody in the 
period studied. 
HBsAg AND GLOMERULONEPHRITIS 
The incidence of glomerulonephritis in association with 
chronic active hepatitis of unknown etiology has been 
reported to be 7% (Mistilis and Blackburn, 1970). 
Eknoyan et al. (1971) studied renal biopsy specimens 
from 7 patients with acute viral hepatitis. Four out of 
these patients were HBsAg positive. Lightmicroscopical 
changes were described as of very minor degree. IF-study 
demonstrated focal nodular deposits of IgG, IgH, IgA and 
B1C in all seven biopsy specimens. However, the presence 
of HBsAg was not tested by the IF-technique. Electron 
microscopic examination revealed tubular structures as 
described in association with systemic lupus erythematosus, 
but no HBsAg-associated particles were demonstrated. 
Randall et al. {1971) reported six cases of renal 
manifestations in patients with chronic hepatitis. 
Antibodies against HBsAg were not present in any of the 
patients; the presence of HBsAg was not reported. All 
cases showed membranoproliferative glomerulonephritis. 
Out of four biopsy specimens available for IF-study, two 
showed linear fluorescence of the glomerular basement 
membrane {GBM), when tested with anti-immunoglobulin 
antisera, and all specimens showed lumpy glomerular 
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deposits of complement. Serum antibodies were present 
against human GBM in two cases, against nuclear protein 
in five and against smooth muscle in two. Serum complement 
levels were lowered in five cases. 
The first well-documented case of hepatitis-B 
associated glomerulonephritis with evidence of a causal 
relationship of HBsAg and renal disease was reported by 
Combes et al. (1971). IF-studies revealed granular depo-
sits of IgG, Complement and HBsAg along 
the glomerular basement membrane in a renal biopsy speci-
men showing membranous glomerulonephritis. However, 
circulating immune complexes could not de demonstrated in 
this case 1 using sucrose-gradient ultracentrifugation and 
Clq-precipitation techniques. In addition serum complement 
levels were normal 1 cryoglobulinaemia was not detected and 
serum anticomplementary activity was not present. 
Nowoslawski et al. (1972) studied tissue specimens 
obtained at autopsy from 29 patients who died in the 
course of fulminant hepatitis, subacute hepatitis, chronic 
aggressive hepatitis, postnecrotic liver cirrhosis and 
chronic persistent hepatitis respectively. All cases were 
HBsAg positive. The incidence of clinical manifestations 
of renal disease in these patients was not reported. 
However, chronic membranous glomerulonephritis was 
diagnosed in four cases, and IF-studies revealed granular 
and lumpy deposits of HBsAg, IgG, IgM and BlC along the 
GBM in all four cases. In addition, HBsAg, IgG 1 IgM and 
B1C were demonstrated in small and large arteries showing 
lesions comparable with panarteritis in the healing stage. 
Myers et al. (1973) reported a case of membrana-
proliferative glomerulonephritis associated with persistent 
HBsAg positive hepatitis. IF-studies revealed granular 
deposits of IgG 1 complement and HBsAg. Serum complement 
levels (C3 and C4) were low. 
Three cases of immune complex glomerulopathy in 
association with HBsAg-positive hepatitis were reported 
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by Knieser et al. (1974). The glomerular changes were 
classified as membranous glomerulonephritis, focal glome-
rulosclerosis and membranoproliferative glomerulonephritis 
respectively. Evidence of deposition of HBsAg-containing 
immune complexes was derived from both IF-studies and 
irnrnuno-electron microscopic examination of renal tissue 
biopsy specimens. Liver biopsy specimens from all cases 
showed chronic active hepatitis from the onset or in 
follow-up. Except for the case of membranoproliferative 
glomerulonephritis, which was reported to be normocomple-
mentaemic, no serum complement levels were reported, nor 
studies concerning the detection of immune complexes in 
the serum. 
Kohler et al. (1974) reported one case of membranous 
glomerulonephritis with deposition of immune complexes 
containing HBsAg, as demonstrated by the IF-technique. 
Electron microscopic study did not reveal any particles 
morphologically resembling the spherical 20 nm form of 
HBsAg. A liver biopsy specimen showed chronic active 
hepatitis. Serological tests related to the detection of 
circulating immune complexes included study of complement 
levels of the components Clq, C4, C3 and cs, rheumatoid 
factor, antinuclear antibodies, Clq precipitation and 
cryoproteins. Serial samples taken during 12 months 
showed normal complement levels. Clq precipitins were not 
detected and tests for rheumatoid factor and antinuclear 
antibodies were consistently negative. The analysis of 
cryoproteins demonstrated anti-HBs immunoglobulins at a 
1;32 titre, whereas whole serum was negative for antibody. 
HBsAg was detected in a cryoprecipitate concentration of 
less than 5% of that in whole serum. In addition, IgG, 
IgM and C3 were demonstrated in the cryoprecipitate. 
These findings were interpreted as evidence of circulating 
HBsAg-anti HBs immune complexes in this patient. A second 
patient with HBsAg-anti HBs immune complex glomerulo-
nephritis was identified by these authors, who reported 
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a prevalence of 1.4% (2 out of 145 renal biopsies). 
Brzoska et al. {1974) reported immune complex glome-
rulonephritis in 32 out of 52 unselected kidney biopsy 
specimens from children. In 18 out of these 32 cases with 
immune complex glomerulonephritis HBsAg was identified in 
the glomerular lesions, in addition to Ig and C. In most 
cases, the glomerular lesions were classified as membrane-
proliferative glomerulonephritis (12/18). In addition, 
two cases of membranous, intracapillary and extracapillary 
proliferative glomerulonephritis respectively were 
reported. 
Mcintosh et al. (1976) reported 3 cases of membranous 
glomerulonephritis with glomerular deposition of HBsAg 
and Ig. No histological data concerning the associated 
type of hepatitis were reported. 
A summary of the histological diagnoses on renal and 
liver biopsy specimens in cases of hepatitis B associated 
glomerulonephritis with glomerular HBsAg containing 
deposits, demonstrated by IF, is given in table 2. 
These data indicate that glomerulonephritis with HBsAg-
deposition in the glomeruli occurs predominantly in 
association with CAH. 
DETECTION TECHNIQUES USED FOR HBsAg-ANTI HBs I!>1MUNE 
COMPLEXES 
Shulman and Barker (19691 demonstrated anticomple-
mentary (AC) activity of the serum at some time during 
hepatitis in 95% of 130 volunteers exposed parenterally 
to blood products known to transmit viral hepatitis. 
This AC-activity was attributed to immune complexes 
consisting of HBsAg and antibody. Further evidence that 
antigen-antibody complexes accounted for the AC-activity 
was provided by the ability of excess antigen or antibody 
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Table 2 
HistOlogical diagnoses on renal and liver biopsy specimens in cases of he~titis B associated 
glomerulonephritis with glomerular HBsAg containing deJ?Ositions dem:mstrated by IF. 
Author 
Combes et al. (1971) 
Renal biopsy 
specimen 
membranous GN 
Nowoslawski et al. (19721 membranous GN 
No of 
cases 
1 
4 
Liver biopsy 
specimen 
AcH (--CPH?) 
CAH 
No of 
cases 
1 
3 
"fulminant hepatitis" 1 
Myers et al. (1973) 
Knieser et al. (1974) 
Kohler et al. (1974) 
Mcintosh et al. (1976) 
Brzosko et al. (19741 
membranoproliferative GN 
membranoproliferative GN 
membranous GN 
1 
1 
l 
focal glomerulosclerosis 1 
membranous GN 
membranous GN 
rnembranoproliferative GN 
membranous GN 
endocapillary GN 
extracapillary GN 
1 
3 
12 
2 
2 
2 
CAH (+ cirrh.) l 
CAH 3 
CAH 1 
not reported 
not reported 
to reverse it. Although the activity of liver disease was 
mentioned, systemic manifestations attributable to circu-
lating immune complexes were not reported. 
Almeida and Waterson (1969) described in an electron 
microscopic study of the sera of HBsAg positive patients 
spherical and tubular particles with a diameter of 
20-25 nm, the tubular structures having lengths that 
varied from 30 to 700 nm. In one subject without clinical 
signs of liver disease, these particles showed a random 
distribution. However, addition of rabbit-anti HBsAg 
immunoglobulin caused aggregate formation and clumping of 
these particles. In a patient with chronic active hepatitis 
both aggregated and at random distributed particles were 
demonstrated, representing HBsAg-anti HBs immune complexes 
in antigen excess. The serum from a fatal case of acute 
hepatitis contained numerous aggregates, interpreted as 
HBsAg-anti HBs immune complexes in antibody excess, 
since no free particles were seen in this specimen. Al-
though the occurrence of immune complexes in the sera from 
these patients correlated well with the severity of liver 
disease, systemic disease due to circulating immune 
complexes was not reported. 
Millman et al. (1970) mentioned the possibility that 
HBsAg may be undetectable by immunodiffusion in sera 
containing anti HBs. These authors reported the use 
of dissociation of immune complexes as a method for their 
detection. Immune complex dissociation was achieved by 
ultracentrifugation in cases of low affinity complexes 
and by enzyme treatment in cases of high affinity com-
plexes. 
The changes in physicochemical properties of HBsAg 
and anti-HBs after complex formation were used by Prince 
and Trepo (1971), who analyzed the sera from patients 
with hepatitis and polyarteritis nodosa by rate-zonal 
density gradient centrifugation. When antigen-containing 
sera were centrifuged through gradients containing 
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10-40% sucrose during 2 hours at 25,000 rpm the antigen 
sedimented as a single peak with a sedimentation coeffi-
cient of approximately 110 S. However, when sera con-
taining both antigen and antibody were centrifuged through 
gradients of this type, antigen was found to sediment at 
varying rates between 110 S and 1000 S or more. The results 
of these studies are mentioned under "HBsAg and vasculitis". 
The interaction of the Clq component of complement 
with aggregated immunoglobulin and immune complexes, 
resulting in Clq-precipitation, has been applied to the 
detection of immune complexes in sera from patients with 
SLE, rheumatoid arthritis and polyarteritis nodosa, using 
the agar gel diffusion method (Agnello, et al., 1970, 
Gocke et al., 1971). 
McAuliffe, Kachani and Gocke (1973) reported a 
bioassay, based on the inflammatory reaction in the skin 
of guinea pigs after intradermal injections of serum 
fractions containing in vitro prepared HBsAg-anti HBs 
immune complexes. Both antigen-excess and equivalence-
zone complexes were tested. Antigen-excess immune complexes 
produced an immediate increase in vascular permeability, 
whereas equivalence-zone precipitates showed no signifi-
cant differences with controls. 
Nydegger et al. (1974) described a method for immune 
complex detection based on both the C1q binding properties 
of immune complexes and on their large molecular size, 
using fractionated precipitation of immune complex bound 
and free 125 r C1q in polyethylene glycol (PEG). These 
authors studied 54 sera from 49 HBsAg-positive subjects. 
Eighteen healthy carriers did not exhibit increased 
125
r Clq precipitation when compared to normal human 
donors. However, 4 out of 7 patients with chronic persis-
tent hepatitis and 7 out of 24 patients with acute 
. h h d . d 125 . trans1ent epatitis a 1ncrease I C1q preclpitation 
values. It was stress-ed that no correlation between the 
increased 125 r Clq precipitation and the clinical status 
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of the patient could be demonstrated, and systemic disease 
due to circulating immune complexes was not reported. 
Woolf et al. (1975) studied 36 sera from HBsAg-
positive individuals, including cases of histologically 
confirmed cirrhosis, chronic aggressive and chronic 
persistent hepatitis and focal necrosis, as well as cases 
without histological damage of the liver. In all sera 
20 nm particles predominated. However, aggregation of 
particles into complexes was not observed without the 
prior addition of anti-HBsAg antiserum. 
Wands et al. (1975) analyzed the occurrence and 
composition of cryoprecipitable proteins in the sera from 
patients with HBsAg-positive hepatitis. The results of 
these studies are summarized under "HBsAg and arthritis". 
Theofilopoulos, Wilson and Dixon (1976) reported the 
use of a human lymphoblastoid cell line with B cell 
characteristics, derived from a Burkitt lymphoma (Raji 
cells) as an in vitro detection technique for circulating 
immune complexes. These cells lack membrane bound immuno-
globulin, but they have receptors for IgG Fe, C3b, C3d and 
C1q. Via the C-receptors immune complexes in human sera 
may be bound to the Raji cells and in turn quantitated by 
measuring the uptake of radiolabeled rabbit-anti-human 
antibody. The amount of immune complexes present is 
expressed as the amount of aggregated human immunoglobulin 
inducing an equivalent uptake of radiolabeled antibody. 
The antigens involved may be identified, using the 
immunofluorescence technique with FITC-labeled antisera, 
as was demonstrated with HBsAg-containing immune complexes 
The authors reported in 12 out of 19 patients with acute 
HBsAg-positive hepatitis the presence of circulating 
immune complexes, as well as in 8 out of 59 asymptomatic 
HBsAg carriers. The occurrence of systemic disease, related 
to circulating immune complexes was not reported. 
Mcintosh, Koss and Gocke (1976) studied the nature 
and incidence of cryoproteins in HBsAg positive patients. 
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Their results indicate that the amount of cryoprecipitable 
material is highest in acute hepatitis. Furthermore, 
these authors stressed that systemic disease (i.e. vascu-
li ti,s and glomerulonephritis) occurred predominantly in 
patients with chronic hepatitis, the cryoprecipitate 
containing large amounts of antigen but little antibody. 
In contrast, in patients with chronic hepatitis without 
vasculitis, both antigen and antibody was detected in the 
cryoprecipitate. 
In vitro studies, using artificially prepared immune 
complexes of HBsAg and human anti-HBs have demonstrated 
that HBsAg-anti HBs immune complexes can be detected by 
phagocytosis by PMN. The detectability of the immune 
complexes was demonstrated to be dependent on the antigen/ 
antibody ratio, and both Ig and HBsAg were identified 
within the Pl'1N, if this ratio ranged from 5 to 0. 2 
(Steffelaar et al., 1977). 
From this review of the literature it is concluded 
that evidence of the presence of circulating immune 
complexes in hepatitis B patients has been presented by 
several authors, although involvement of HBsAg in immune 
complex formation was demonstrated in a minority of the 
studies reported. Several authors discussed the relation 
of liver damage and circulating immune complexes. However, 
the results of the imrnune complex detection techniques 
in relation to systemic manifestations, attributable to 
circulating immune complexes on one hand and histological 
character·ization of the liver disease on the other hand, 
has not been analysed. 
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Chapter V 
Hepatitis B surface antigen (HBsAg) and systemic disease. 
A clinico pathological study. 
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In this chapter a study of systemic manifestations in 
relation to hepatitis B and the occurrence of circulating 
immune complexes is reported. The PMN phagocytosis test 
was used as parameter for the presence of immune complexes 
in the circulation. 
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SUMMARY 
The occurrence of manifestations of systemic disease 
in 107 HBsAg seropositive subjects with histologically 
staged liver disease was screened. In addition, 93 cases 
of immune complex glomerulonephritis were screened for 
HBsAg-containing deposits in glomeruli and vessel walls. 
The presence of immune complexes in the serum of 35 HBsAg-
seropositive subjects was tested by immunofluorescence 
study of normal donor polymorphonuclear leucocytes (PMN) 
after incubation with serum from these patients. In this serie~ 
the incidence of arthralgia in the prodromal or early 
acute phase of hepatitis B was about 20%. Convincing 
evidence of the involvement of HBsAg in the pathogenesis 
of these joint symptoms was lacking. Polyarteritis nodosa 
(PAN) in association with chronic persistent hepatitis B 
was present in one case. Although the PMN phagocytosis 
test indicated the presence of circulating immune complexes, 
a causal relationship of the vasculitis and HBsAg could 
not be demonstrated. No case of HBsAg-associated glomeru-
lonephritis was present in the material studiE'd. The 
presence of circulating immune complexes was demonstrated 
by the PMN phagocytosis test only in cases of chronic 
active hepatitis, except for two cases of PAN, associated 
with chronic persistent hepatitis in one. Since 8 out of 
10 cases of glomerulonephritis with glomerular HBsAg 
deposits have been reported in association with chronic 
active hepatitis, these data suggest that the PMN phagocy-
tosis test is able to detect and discriminate potential 
pathogenic circulating immune complexes. 
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INTRODUCTION 
Arthritis, glomerulonephritis and vasculitis have 
been reported in the cnurse of he..,atitis associab~d wj_th 
hepatitis B surface antigen (HBsAg) {2, 7 1 11, 16, 24, 26, 
28, 31, 34, 38, 46) Deposition of circulating immune 
complexes is supposed to be the cause of these complications, 
and the presence of both HBsAg and immunoglobulinR (Ig) 
ha.s been reported in biopsy specimens of the tissues 
involved (4, 7, 17, 24, 26, 29, 31, 32). However, as 
compared with a prevalence of 1.90 per 1,000 of HBsAg-
associated hepatitis (42), well documented cases of 
systemic disease caused by deposition of HBsAg-containing 
i~~une complexes are ra~e, and very few cases have been 
published presenting evidence of HBsAg-containing immune 
complexes both in the serum and in renal or vascular 
tissues from the same patients. 
Several a_uthors have demonstrated the occ'.lrrence of 
HBsAg-containing immune complexes in the 3era from up to 
95% of the patients with HBsAg-associated hepatitis 
(29, 33, 35, 39, 44). Therefore only a small minority of 
the irnr:mne complexes detected by the techniques used can 
be relevant as far as immune complex deposition resulting 
in clinically manifest systemic disease is concerned. 
In vitro studies, using artificially prepared immune 
complexes of HBsAg and human anti-HBsAg immunoglobulin 
(anti-HBs) have demonstrated that HBsAg-anti HBs immune 
complexes can be detected by phagocytosis by polymorpho-
nuclear leucocytes (PMN) (41). In the same study it was 
reported that phagocyt-_osis of HBsAg-anti HBs innune 
complexes by PMN is dependent on the antigen/antibody 
ratio of the immune complexes, and most readily demonstra-
ted if this ratio ranges from 5 to 0.2. 
Since cnnditions of slight antigen excess are known 
often to result in the formation of pathogenic complexes 
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with subsequent deposition in renal or other tissues 
(9, 10), the HBsAg-anti HBs immune coroplexes demonstrated 
by phagocytosis by PMN might well correlate with the 
presence of pathogenic immune complexes. 
The purpose of the present study was: 
1. to investigate the occurrence of signs and symptoms of 
systemic dis~">ase, possibly related to immune complex 
deposition in patients with HBsAg-associated hepctitis 
and healthy HBsAg-carriers. 
2. to investigate the occurrence of HBsAg in renal tissue 
biopsy specimens, studied by the immunofluorescence 
technique (IF). 
3. to study phagocytosis of HBsAg and Ig by PMN both in 
vitro, and in vivo from the sera of patients with 
HBsAg-associated hepatitis. 
MATERIALS AND METHODS 
HBsAg - seropositi.ve subjects, screened for systemic 
disease. 
In 107 HBsAg seropositive subjects with histologically 
sta.ged liver disease the occurrence of signs and symptoms 
related to systemic disease, presumably due to circulating 
immune complexes, were screened, with special reference 
+:o joint and skin manifestation:= and proteinuria. One 
half of each liver biopsy specimen •::as routinely prepared 
for paraffin sections after fixatio~ in either 2% para-
formaldehyde or 4% buffered formaldehyde. Sections of 
3-4 mu thickness were stained with haematoxylin/azophloxin/ 
safran, elastin-v.Gieson, Periodic acid Schiff with and 
without diastase treatment, Gomori•s reticulin and 
modificated aldehyde thionin (27) staining techniques. 
The other half of each biopsy specimen was frozen in 
liquid nitrogen for IF-study (see below). 
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The cases of chronic hepatitis were histologically 
staged according to the criteria proposed by De Groote 
et al. (8). In the present study, carriers are defined 
as HBsAg-seropositive subjects without clinical and 
biochemical signs of liver disease and a liver biopsy 
specimen showing a normal architecture, no or minimal 
inflammatory infiltration and clusters of "ground glass" 
hepatocytes with a blue staining cytoplasm in the 
aldehyde-thionin staining technique 1 which cells show 
cytoplasmic fluorescence in the IF-technique using rabbit-
anti HBsAg antiserum (19). Most carriers were identified 
by routine serological screening of blood donors, followed 
by taking of a liver biopsy specimen in seropositive 
subjects. Since any type of hepatitis can be asymptomatic, 
it was considered justified to perform a percutaneous 
needle biopsy also in subjects without clinical signs of 
liver damage and with minimal biochemical changes. 
In the course of the hepatitis, skin biopsy specimens 
were taken from 4 patients for lightmicroscopical examina-
tion and IF-study, because of severe itching and urticaria, 
and from one patient a formalin fixed and paraffin embedded 
skin, muscle and fascie biopsy specimen was available 
for lightmicroscopical examination. 
Renal tissue specimens. 
Lightmicroscopical examination and IF study was 
performed on 167 consecutive renal biopsy specimens, 
11 resected kidneys and 14 resected renal allografts. 
Tissue for lightmicroscopical examination was routinely 
prepared for paraffin sections after fixation in 2% para-
formaldehyde. Sections of 2 mu thickness were stained 
with haematoxylin/azophloxin, methenamine silver, elastin 
v. Gieson and PAS-trichrome staining procedures. Tissue 
for IF-study was frozen in liquid nitrogen. 
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PMN phagocytosis test. 
The study comprised 35 HBsAg-seropositive patients 
with histologically Characterized liver disease. One addi-
tional patient with PAN confirmed by skin and renal biopsy 
specimens was HBsAg seronegative at the time, the biopsy 
specimens were taken, but 6 weeks later low titers of 
HBsAg could be demonstrated. 
Peripheral blood PMN were isolated from heparinized 
venous blood from these patients (direct test) as 
described elsewhere (41). In addition, normal donor HIJ:N 
were incubated with serum from these patients (indirect 
test) and subsequently washed, fixed and frozen as 
described previously (41). 
The sera were allowed to clot during 30 min at 37oC 
and either freshly incubated with normal donor PMN or 
stored at -70oC. Some serum samples were tested both 
fresh and after freezing and thawing several times. 
In the serum samples used for the indi-rect PMN-phagocytosis 
test, the HBsAg and anti-HBs titres were determined by 
haemagglutination (inhibition) techniques (36), as well as 
the Clq and C3 levels. 
Immunofluorescence procedure. 
From the frozen tissue specimens and PMN suspensions 
4 mu cryostat sections were cut and prepared for IF study. 
The indirect immunofluorescence technique was used for the 
demonstration of IgG, IgM, IgA and C as described previously 
(40). As second layer horse anti-rabbit antiserum 
conjugated to fluorescein isothiocyanate (FITC} was used. 
The presence of HBsAg was determined with the direct 
technique using rabbit anti-HBsAg antiserum (37), conjuga-
ted to FITC and adsorbed with sonificated donor PMN. 
All antisera were prepared and tested for specificity 
in the Central Laboratory of the Netherlands Red Cross 
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Blood Transfusion Service. Slides were read in a Leitz 
Dialux fluorescence microscope equipped with incident 
illumination. A Xenon Lamp {Osrarn XBO. 150 W) was used 
for excitation. 
The percentage of PMN with fluorescent inclusions 
was determined as previously described {40). Slides with 
up to 10% of the PMN showing inclusions were scored as +, 
10 to 20% was scored as ++ and 1% or less of the PMN 
showing inclusions was scored as -
RESULTS 
HBsAg-seropositive subjects, screened for systemic 
disease. 
The histological findings, epidemiology and manifes-
tations of systemic disease in the HBsAg-seropositive 
subjects studied are summarized in table 1. Arthralgia 
was present in about 20% of the cases, both in male en 
female patients. However, arthritis with redness, swelling 
or increased local temperature has not been noted. 
The skin biopsy specimens from 4 patients showed 
minimal perivascular edema and lymphocytic infiltrationi 
by IF study no HBsAg-deposition could be demonstrated, 
nor Ig and C. 
Proteinuria was noted in one case, complicated by 
severe pyelonephritis, resulting in urosepsis and death. 
Since permission for autopsy could not be obtained, a 
histological diagnosis of the renal disease in this patient 
is not available. 
Both the skin and muscle biopsy specimens from the 
case complicated by PAN showed characteristic fibrinoid 
necrosis and inflammatory infiltration of the walls of 
arterioli {Fig.!). IF-studies, performed on sections from 
the formalin fixed and paraffin embedded skin and muscle 
biopsy specimens did not demonstrate deposition of either 
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Table 1 
Histological findings, epidemiology and nmrifestations 
of systemic disease in 107 HBsAg-seropositive subjects. 
Patients 
Histology 
AcH 
CPH 
CAH 
Cirrh. 
Carrier 
Aspecific 
Epidemiology 
Drug addict 
Homosexual 
Venereal disease 
Tattooing 
Blood transfusion 
Occupational 
Icterus 
Systemic disease 
Urticaria/Rash 
Arthralgia 
Arthritis 
Proteinuria 
PAN 
AcH acute hepatitis 
Male 
so 
15 
16 
36 
15 
10 
2 
8 
8 
14 
7 
8 
2 
26 
1 
16 
1 
1 
CPH chronic persistent hepatitis 
Ferrale 
27 
9 
8 
4 
1 
5 
1 
2 
4 
6 
13 
3 
5 
CAH chronic active (aggressive) hepatitis 
Cirrh. cirrhosis 
PAN ~ polyarteritis nodosa 
61 
Fig. l 
Fig. 2 
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Arteriole with segmental fibrinoid necrosis and 
inflammatory infiltration by lymphocytes. 
Haematoxylin and azophloxin, X 700. 
Liver tissue with a solitary 11 ground glass" cell. 
Aldehyde-thionin, X 750. 
Fig. 3 
Fig. 4 
Fig. 5 
ERRATUM 
Fig. 3 Fig. 4 
A solitary hepatocyte showing bright cytoplasmic 
fluorescence by IF study using rabbit anti HBsAg 
antiserum, X 550. 
Cell-membrane bound "diffuse" inununofluorescence 
of hepatocytes, using rabbit anti HBsAg anti-
serum. X 550. 
Renal glomerulus showing proliferation of the 
parietal epithelial cells and crescent formation. 
l1ethenamine silver, X 360. 
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Fig. 3 
Fig. 4 
Fig. 5 
Fig. 3 Fig. 4 
A solitary hepatocyte showing bright cytoplasmic 
fluorescence by IF study using rabbit anti HBsAg 
antiserum, X 550. 
Cell-membrane bound ndiffuse 11 immunofluorescence 
of hepatocytes, using rabbit anti HBsAg anti-
serum. X 550. 
Renal glomerulus showing proliferation of the 
parietal epithelial cells and crescent formation. 
l"iethenamine silver, X 360. 
63 
HBsAg or Ig and C in the vessel walls. The liver biopsy 
specimen from this case showed a chronic persistent 
hepatitis with scattered 11 ground glass" cells (Fig. 2) 
showing bright cytoplasmic fluorescence by IF study using 
anti HBsAg antiserum (Fig. 3}. 
All cases of CAH showed cell membrane bound 
fluorescence of the hepatocytes throughout the biopsy 
specimen ("diffuse pattern" according to Roos et al., 
(37) using the IF technique with anti HBsAg antiserum 
(Fig. 4). 
Renal tissue specimens. 
The histological diagnoses in the kidney biopsy 
specimens are summarized in tables 2 and 3. Granular 
deposits of Ig and C were identified along the 
glomerular basement membrane (GBM) and/or in the mesangium 
in all cases of endocapillary glomerulonephritis (GN), 
membranous GN, mernbranoproliferative GN, local-focal GN 
and in the case of rapidly progressive GN. Such deposits 
were also demonstrated in all cases of extracapillary GN, 
except for two cases of diabetic glomerulopathy without 
deposits of Ig and C. In one case of diabetic glomerulo-
pathy linear fluorescence of IgG along the GBM was 
demonstrated, as described by Gallo (13}; this case was 
not interpreted as immune complex GN. 
Because of the lightmicroscopical and IF findings it 
is concluded that in the 192 renal tissue specimens studied 
93 cases of GN are caused by deposition of immune complexes. 
Three kidney allograft recipients were HBsAg sero-
positive. Liver biopsy specimens of these patients were 
not available. In one case the kidney biopsy specimen, 
taken ~ hour after revascularisation of the allograft, 
showed bright granular fluorescence along arteriolar 
vessel walls with antisera against IgM, C and HBsAg. 
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"' l.n 
Tissue 
Ne phrectorcy 
Transplantectomy 
Biopsy 
! hour after 
transplantation 
Needle biopsy 
No 
5 
14 
53 
74 
Table 2 
Histological diagnoses on renal tissue from adults ( > 15 years) 
Diagnosis 
End stage kidney 
Pyelonephritis 
Interstitial nephritis 
Rejection 
Circulatory obstruction 
Necrosis 
Candida albicans abscesses 
Recent ischaemic lesion 
Praeexistent ischaemic lesions 
Praeexistent extracapillary GN 
Praeexistent endocapillary GN 
Ischaemic lesions 
Endocapillary GN 
Extracapillary GN 
Membranous GN 
Local - focal GN 
DD: Rapidly progressive GN/PAJ'if 
Interstitial nephritis 
Amyloidosis 
Rejection 
Inmune complex GN 
No 
3 
1 
1 
6 
5 
2 
1 
42 
7 
3 
1 
12 
20 
20 
7 
6 
1 
3 
2 
3 
55 
Remarks 
Phenacetine abuse 
In one HBsAg-deposition 
In one HBsAg-deposition along arterioli 
Diabetes mellitus in 3 cases 
Polyarteritis nodosa in 4 cases 
Phenacetine abuse 
"' 
"' 
Table 3 
Histological diagnoses on renal tissue from children (<15 years) 
Tissue No Diagnosis No Remarks 
Nephrectomy 6 Membranoproliferative GN 2 
Bleeding after biopsy procedure 1 
Focal glomerulosclerosis 1 
End stage kidney 2 
Biopsy 2 Recent ischaemia lesion 2 
~ hour after 
transplantation 
Needle biopsy 38 Endocapillary GN 20 
Extracapillary GN 12 
Local-focal GN 3 
Membranous GN 1 
AmYloidosis 1 
Interstitial fibrosis 1 Leucaemia in remission 
Immune complex GN 38 
However, at autopsy, neither in the transplanted kidney, 
nor in the own kidneys of the patient could HBsAg, Ig or 
c be detected by IF, 3 weeks after transplantation. The 
patient died of bronchopneumonia with lung abscesses. 
Two cases showed only slight edema and shedding of tubular 
epithelium in the ~ hour biopsy specimen. However, three 
weeks after transplantation transplantectomy was performed 
in one case because of ischaemic necrosis of the kidney, 
caused by arterial thrombotic obstruction. The resected 
kidney showed granular deposits of HBsAg, IgM and C along 
vessel walls and glomerular capillary loops. The presence 
of HBsAg could not be demonstrated in any of the other 
kidney biopsy specimens studied. 
In one of the four cases of PAN, histologically 
confirmed by a renal and skin biopsy specimen, HBsAg 
could not be demonstrated at the time the biopsy specimens 
were taken, but 6 weeks later low titers of HBsAg were 
present. A liver biopsy specimen of this case was not 
available. The renal biopsy specimen showed a focal extra-
capillary proliferative glomerulonephritis with crescent 
formation (Fig. 5). 
PMN phagocytosis test. 
The results of the PMN phagocytosis test, in relation 
to the histological diagnoses on the liver biopsy specimens 
and the serological findings concerning complement levels 
and titres of HBsAg and anti HBs are summarized in table 4. 
The presence of both Ig and C in the PMN was interpreted 
as suggestive of immune complexes in the serum tested, and 
was demonstrated in 4 out of 16 cases of CAH and in two 
cases of PAN. Evidence of HBsAg containing immune complexes 
was obtained in one additional case of CAH by demonstration 
of HBsAg in association with Ig and C in the PMN. 
The liver biopsy specimen in one of the cases with 
PAN showed CPH. The other case of PAN was confirmed by a 
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"' Table 4 
"' Histological and serological findings in 35 HBsAg seropositive patients and in one case of PAN 
Pr1N phagocytosis test 
Direct Indirect serum titer 
Pat. m/f age Histol.diagnosis HBsAg Ig c HBsAg Ig c C1q C3 HBsAg anti HBs 
1 rn CAH + 
2 rn 38 ~vere CAH + 
3 f 24 AcH + 
4 rn 38 CPH/slight CAH N.D. - + 
5 f 28 AcH + necrosis N.D. + 
6 rn 65 Girrh. N.D. - + 
7 rn 40 AcH N.D. + 
8 m 44 CAl-l + fibrosis N.D. - + 
9 m 60 AcH N.D. - 103 95 12,800 
10 m 40 Severe CAH + cirrh. N.D. ++ ++ ++ 138 131 l,eJOO 
11 m 21 CAH + cirrh. N.D. - - 99 109 2,000 
12 f 26 A ell N.D. 
- 82 89 3,200 
13 m 9-l CAH + cirrh. N.D. + + + 
14 rn 50 CAH + cirrh. N.D. - 95 68 6,~00 
15 m 26 H=al thy carrier N.D. 59 71 + 
1G m !18 CAH + cirrh. N.D. + 
17 rn 43 AcH N.D. - - + 
"' 
"' 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
m 23 
m 32 
m 73 
m 53 
m 32 
m 20 
m 57 
m 30 
m 29 
f 76 
f 19 
m 28 
m 26 
f 33 
m 33 
m 39 
m 63 
m 34 
m 30 
AcH N.D. 
No liver tissue + + 
available - + + 
CPH N.D. 
CAH + cirrh. + + 
AcH -
CPH 
CPH - -
CAH -
CPH - -
CAH + cirrh. -
CAH (severe) 
AcH -
CPH - -
CPH -
CAH -
fualthy carrier - -
CAH + cirrh. -
CAH + 
AcH - -
- - + 
+ + 118 41 
+ + 102 56 64 
+ + 79 68 51,200 
+ + 136 109 3,200 128 
N.D. + 
-
82 97 1,000 
- -
122 89 2,000 64 
89 51 3,200 16 
108 Bo 12,800 
122 119 6,400 
- + + 79 95 + 
II 39 8 
122 97 3,200 
+ 
- 99 68 3,200 
- - 68 56 32 
+ + 82 So 12,800 
108 68 3,200 
- 56 165 64 
65 126 16 
39 87 6 
42 124 
34 79 
59 99 
renal (Fig. 5) and skin biopsy specimen, 6 weeks before 
HBsAg could be demonstrated in the serum. A liver biopsy 
specimen of this patient was not available. 
None of the patients had signs or symptoms of systemic 
disease at the moment of blood sampling, except for the 
two cases of PAN and patient ( 36 ) , who had arthralgia 
at the time that two of the six weekly obtained blood 
samples were taken. However, five patients had a history 
of arthralgia in the prodromal phase of hepatitis some 
weeks earlier 1 and a rash had been noted in one case. 
DISCUSSION 
The striking male preponderance of HBsAg-associated 
hepatitis in this study confirms the findings of several 
authors (18, 42) and is caused predominantly by the 
frequent occurrence of CAH in men, often complicated by 
cirrhosis, as has also been reported by Klatskin (23). 
Some of the high risk groups (i.e. hospital and 
laboratory personel, drug addicts, tattooed subjects) are 
directly related to an increased chance of parenteral 
infection by contaminated blood. The striking number of 
male homosexual subjects and patients with venereal 
disease as found in our series, has also been noted in 
other studies (12, 22). Microtrauma at sexual intercourse 
has been suggested as a possible cause of the increased 
risk of hepatitis B infection in these subjects (43). 
Several studies (15, 25) have drawn attention to 
extrahepatic manifestations of viral hepatitis and the 
role of circulating immune complexes in the pathogenesis 
of these syndromes. Gocke (15) recognized three types of 
syndromes: first a serum sickness like prodrome of acute 
hepatitis consisting of urticaria, rash, polyarthralgia 
and sometimes arthritis in 15 - 20 % of patients. Secondly, 
he noted an incidence of 30-40% of HBsAg-antigenaemia in 
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patients with PAN, and thirdly, an immune complex type of 
glomerulonephritis, usually in association with chronic 
active hepatitis. 
The frequency of joint manifestations in hepatitis B 
in our study (21 out of 107 cases) confirms the findings 
of Gocke (15) and Mosley and Galambos (30) who reported 
an incidence of 20.6% of joint syrnp~oms in hepatitis 
after specifically asking for it. However, arthritis with 
evidence of redness, swelling and/or increased local 
temperature was not present in any of the patients studied. 
In a review of the literature, Alarcon and Townes (1) 
reported that arthritis is a relatively uncommon compli-
cation of hepatitis while arthralgia occurs much more 
frequently. These authors reported no sex differences for 
the incidence of arthralgia in patients with hepatitis, 
which is confirmed in our study (16 out of 80 male patients 
and 5 out of 27 female patients). In contrast, they 
reported a slight predominance of female patients in cases 
cowp1icated by arthritis ( 3:2 ) . However, Kohler (25) 
reported that joint and skin symptoms occurred significant-
ly more frequently in female compared to male hepatitis B 
patients (48 and 15 % resp.). 
In most of our cases complicated by joint and skin 
manifestations, the symptoms occurred during the prodromal 
and/or early acute phase of hepatitis, as was also reported 
by Gocke (15), except for one case with urticaria occurring 
shortly before serological tests indicated the presence 
of anti HBs instead of HBsAg. 
Although the most attractive hypothesis for the 
pathogenesis of skin and joint manifestations is the 
deposition of circulating immune complexes, followed by 
an inflammatory response, histological and IF evidence 
of such complex deposition in the tissues is lacking. 
In our study, 4 skin biopsy specimens, taken because 
of severe itching and urticaria, did not show deposition 
of HBsAg or Ig, as demonstrated by IF. Synovial biopsy 
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specimens were not available. 
Except for one synovial biopsy specimen examined by 
lightmicroscopical and IF techniques {ll) without Ig and 
C deposition {HBsAg not tested) and one skin biopsy 
specimen examined only by light microscopy (48) no 
histological data are available in the literature studied. 
Evidence of circulating immune complexes in the 
prodromal syndrome of arthralgia and rash of acute hepatitis 
is mainly based on complement component studies (2, 28, 
34, 48). However, involvement of HBsAg in complex formation, 
resulting in low levels of C-components, was not demon-
strated. Onion et al. (34) reported that in no instance 
HBsAg and anti HBs were detected together in the same 
serum samples from 3 patients with active arthritis, 
although all patients showed low CH50-values. 
None of the patients studied by Alpert et al. (2) had 
demonstrable anti HBs in their serum during active 
arthritis, nor in convalescence or remission, and it was 
stressed that serum HBsAg titres were high. However, 
because of the results of the study of experimental serum 
sickness, indicating that conditions of slight antigen 
excess may result in pathogenic immune complexes (6, 9), 
low serum titres of HBsAg might be expected if pathogenic 
circulating immune complexes are present. 
Therefore, we conclude that complement component 
studies have provided circumstantial evidence of the 
presence of circulating immune complexes 1 although in-
volvement of HBsAg has not been demonstrated. The possibi-
lity of other hepatitis B associated antigens (e.g. hepati-
tis B core antigen: HBcAg) being responsible for the 
formation of pathogenic complexes should be considered. 
The appearance of anti HBcAg antibodies (anti HBc) at the 
beginning of clinical signs of acute hepatitis (21) 
coincides well with the expected sequence of serological 
events if HBcAg-anti HBc immune complexes are responsible 
for skin and joint manifestations in the prodromal phase 
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of acute hepatitis. 
Analysis of cryoprecipitable proteins in serum from 
hepatitis B patients has provided evidence of HBsAg 
containing circulating immune complexes (29, 47). However, 
the results obtained from cryoprotein analysis in relation 
to clinical manifestations of systemic disease are 
controversial. Wands et al. (47) reported both HBsAg and 
anti HBs in the cryoprecipitate in one out of three 
patients with acute hepatitis complicated by arthritis, 
while both antigen and antibody disappeared from serum 
and cryoprecipitate when the arthritic symptoms subsided. 
Mcintosh et al. (29) reported the highest amounts of 
cryoprecipitable material in patients with acute hepatitis 
(a relation to systemic disease is not reported), but 
stressed that systemic disease occurred predominantly in 
patients with chronic hepatitis. These authors demonstra-
ted both antigen and antibody in the cryoprecipitates 
from patients with chronic hepatitis without vasculitis, 
while Sergent et al. (38) in a study concerning longterm 
observations in hepatitis B patients with PAN, were not 
able to demonstrate cryoglobulins in any of the patients 
studied. 
Therefore we conclude that cryoprotein analysis may 
contribute to the detection of circulating immune com~lexes, 
although the reports published so far indicate that their 
presence does not show significant correlation with 
systemic disease in hepatitis B. 
A causal relationship between hepatitis B and PAN 
could not be proven in the one case of PAN in association 
with chronic persistent hepatitis in our study. Deposition 
of HBsAg-containing immune complexes in the vessel walls 
could not be investigated, since frozen biopsy specimens 
were not available for IF-study. The results of the 
indirect PMN phagocytosis test were identical with those 
in a case of PAN, in which HBsAg was first demonstrated 
in low titres 6 weeks after the histological confirmation 
73 
of arteritis and glomerulonephritis. It is suggested 
that circulating immune complexes without detectable 
HBsAg were present in the serum during active vasculitis 
in these cases. 
Histological and IF data on 19 cases of PAN in 
association with HBsAg were reported by several authors 
(3, 14, 17, 20, 32) In two cases reported by Gocke (17) 
and in 6 of Nowoslawski 1 s cases (32) deposits of both 
HBsAg and Ig in the vessel walls were demonstrated. 
Although HBsAg, without Ig and C was demonstrated in 
vessel walls in the cases of Gerber et al. (14) and Baker 
et al. (3), .these deposits might be secondary to tissue 
damage, as was concluded by Gerber et al. (14). Convin-
cing histological evidence of involvement of HBsAg 
in the pathogenesis of PAN was also lacking in the 5 cases 
of Heathcote et al. (20) and in 4 of Gocke•s cases (17). 
No IF-studies including anti-HBsAg antiserum were 
performed in the cases of Prince and Trepo (35), Kohler 
(25), Sergent et al. (38) and Duffy et al. (ll) and 
histological data concerning the cases of Trepo et al. 
(46) are not reported. In contrast to the joint and skin 
manifestations of the serum sickness like prodrome of 
acute hepatitis, data compiled from the studies of Trepo 
et al. (45), Heathcote et al. (20), Gerber et al., (14) 
Baker et al., (3), Nowoslawski et al. (32), Sergent et 
al. (38) and Duffy et al. (ll) indicate that the 
frequency of hepatitis B associated PAN is very low and 
that no significant relation to any of the histological 
types of hepatitis can be recognized. 
Glomerulonephritis was not present in the 107 cases 
of hepatitis B studied. Although proteinuria was noted 
in one case, this could well be explained by an exacer-
bation of chronic pyelonephritis, ultimately resulting 
in urosepsis and death. On the other hand, in IF-studies 
on 93 cases of glomerulonephritis, presumably caused by 
deposition of immune complexes, HBsAg could not be 
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demonstrated in any of the biopsy specimens. The findings 
of HBsAg, IgM and C deposits in a resected renal allograft 
showing extensive ischaemic necrosis confirms the findings 
of Gerber et al. (14), who reported HBsAg deposition in a 
renal infarction and suggested that these deposits were 
secondary to tissue damage. We have no satisfactory 
explanation for the deposition of HBsAg, IgM and C along 
arteriolar vessel walls in the renal biopsy specimen, 
taken half an hour after revascularisation of the allo-
graft, in one out of three HBsAg seropositive kidney 
transplant recipients. Immune complex glomerulonephritis 
could not be confirmed at autopsy 3 weeks after trans-
plantation, and at that time HBsAg could not be detected 
in the renal allograft. 
In the literature studied, 10 cases of glomerulo-
nephritis with HBsAg containing glomerular immune complex 
deposits are reported in association with histologically 
typed hepatitis. (7, 24, 26 1 31 1 32). In addition 1 21 
cases of glomerulonephritis with HBsAg containing deposits 
are reported without histological data concerning he~atic 
involvement (4 1 29). In most cases (8/10) the diagnosis 
on the liver biopsy specimen was chronic aggressive 
hepatitis. Although in Myers' case (31) the liver biopsy 
specimen was interpreted as chronic persistent hepatitis, 
neither the published photomicrograph nor the histologic 
description in the text are consistent with this diagnosis 
and it is most likely that chronic aggressive hepatitis 
with cirrhosis is the correct diagnosis. Thus, in contrast 
to the findings in hepatitis B associated PAN, glomerulo-
nephritis occurs predominantly in association with CAH. 
Furthermore, HBsAg-containing immune complex deposits 
have been demonstrated in most cases of hepatitis B 
associated glomerulonephritis, as opposed to many cases 
of hepatitis B associated PAN lacking IF evidence of 
HBsAg deposition . The startling prevalence of HBsAg in 
children with immune complex glomerulonephritis (18/32) 
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as reported by Brzoska et al. (4) was not confirmed in 
our study (o/38) nor by Knieser et al. (24) who mentioned 
a prevalence of 2/145 cases (not specified for children 
and adults). 
The finding of Ig and C phagocytosis by PMN almost 
exclusively from sera of patients with CAH supports the 
observation of Gocke (15) that in this type of hepatitis 
B the risk of complicating systemic disease (i.e. glomeru-
lonephritis) is highest. Only in two cases PMN inclusions 
were demonstrated unassociated with CAH, and both 
concerned cases of PAN with active vasculitis. 
Since IF studies of liver tissue have demonstrated 
the presence of HBsAg along the cellular membrane of 
hepatocytes ("diffuse pattern" according to Roos et al. 
(39) in CAH, it is conceivable that this membrane bound 
foreign antigen induces the host defense mechanism to a 
chronic breakdown of liver cells, ultimately resulting in 
fibrosis or cirrhosis. In addition, shedding of cell 
membrane bound antigen-antibody complexes may occur, and 
this is probably reflected by phagocytosis by PMN. When 
elimination of the "shedded 11 inunune complexes is insuffi-
cient, deposition in vessel walls or glomeruli with 
subsequent tissue damage may result. This mechanism may 
be independent of the production of HBsAg, and therefore 
also of serum titres of HBsAg. This is confirmed by the 
fact that a significant relation between HBsAg serum 
titres on one hand and either the histological type of 
hepatitis or the presence of inunune complexes as demon-
strated by the PMN phagocytosis test on the other hand, 
could not be demonstrated. 
Low complement levels were demonstrated only in one 
case of acute hepatitis, and these might well be due to 
depressed synthesis caused by liver damage. 
The simultaneous occurrence of HBsAg and anti HBs 
was demonstrated in 3 serum samples. In one case this 
finding coincided with the presence of inunune complexes 
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as demonstrated by the PMN phagocytosis test. In the other 
two cases apparently no phagocytizable immune complexes 
were present and in none of these cases systemic manifes-
tations attributable to circulating immune complexes were 
present. 
As outlined above 1 circulating immune complexes may 
well be due to shedding of primarily tissue-bound antigen-
antibody complexes 1 rather than being the result of inter-
action of free circulating antigen and antibody. This 
implies that the simultaneous detection of HBsAg and anti 
HBs in serum samples is probably not a usefull parameter 
for the presence of circulating immune complexes 1 as 
indeed is confirmed by our finding that in the only case 
in which the involvement of HBsAg was demonstrated in the 
PMN phagocytosis test, no detectable anti HBs was present 
in the serum. 
Since in most cases no antigen was identified in the 
PMN, the possibility of an artifact being responsible for 
the in vitro phagocytosis of Ig and C should be considered. 
This phenomenon might be caused by aggregation of Ig, 
induced by freezing and thawing of the serum samples. 
Therefore, the indirect PMN phagocytosis test was performed 
both with fresh seru::n from patients and controls 
and after repeated freezing and thawing of the same samples. 
In no case was phagocytosis of Ig or C demonstrated from 
the frozen and thawed samples only. This finding confirms 
the results of Cats et al. (5), who also reported that 
freezing and thawing of serum samples did not alter the 
results of the indirect P~N phagocytosis test. 
Conclusions: 
l. This study confirms an incidence of arthralgia of 20% 
in the prodromal or early acute phase of hepatitis B, as 
reported in the literature. It is suggested that hepatitis 
B associated antigens, other than HBsAg are involved in 
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the pathogenesis of joint symptoms. Evidence of HBsAg-
containing immune complexes in the pathogenesis of these 
joint symptoms is lacking. 
2. A causal relationship of HBsAg and vasculitis has only 
been demonstrated in a minority of well documented cases 
of PAN. There is no significant relation between the 
histological type of hepatitis and the occurrence of PAN. 
The presence of circulating immune complexes in two cases 
of hepatitis B associated PAN, studied during active 
vasculitis, has been demonstrated by the PMN phagocytosis 
test, although involvement of HBsAg could not be demon-
strated in these cases. 
3. A causal relationship of HBsAg and glomerulonephritis 
has been well documented in the literature. In addition, 
the concomitant histological type of hepatitis is pre-
dominantly CAH. 
4. The results of the PMN phagocytosis test, indicating 
the presence of circulating immune complexes in 5 out of 
16 cases of CAH, fit in well with a hypothesis concerning 
the origin of circulating HBsAg-anti HBs immune complexes 
in hepatitis B based on histological and IF findings in 
liver biopsy specimens and serological studies of the same 
cases, and on an analysis of data compiled from the 
literature. 
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CHAPTE:\. VI: DISCUSSION 
In this thesis some experiments and clinical, 
histological and immunofluorescence studies are reported, 
which were designed with the purpose to develop a 
technique which enables to monitor diseases, mediated by 
circulating immune complexes~ In order to be of clinical 
interest, the technique should meet the following 
requirements: 
1. The results of the test should correlate with clinical 
signs and symptoms of immune complex mediated disease, 
i.e. the test should discriminate potentially pathogenic 
from "harmless" complexes. 
2. The test should include the possibility to detect the 
antigen involved in immune complex formation. 
3. Preferentially, the laboratory outfit needed should 
be relatively simple (e.g. no radiolabeled reagents, 
no need for an ultracentrifuge or an electron micros-
cope), and to perform the test, only commercially 
available reagents should be necessary. 
An immune complex detection technique, which meets 
all these requirements is not available. As outlined in 
chapter I, many of these techniques need the use of 
radiolabeled reagents and/or an ultracentrifuge, e.g. the 
techniques described by Farr (1958), Nydegger et al. 
(1974) and Sobel et al. (1975). Tha Raji cell radio immuno 
assay (Theofilopoulos et al., 1976) requires in addition 
the availability of a lymphoblastoid cell line derived 
from a Burkitt lymphoma. Published reports concerning 
the correlation of the results of an immune complex 
detection technique and clinical signs and symptoms of 
immune complex mediated disease are scarce, and several 
of these studies do not show a significant correlation 
between the complex-mediated disease and the results of 
the techniques used (Prince and Trepo, 1971; Gerber et al., 
1972; Wands et al., 1975; Sergent et al., 1976; Mcintosh 
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et al., 1976). 
Observations concerning phagocytosis of Ig and C by 
PMN, both under experimental conditions in vitro (Parker 
and Schmid, 1962) and in vivo (Cochrane et al., 1959) 1 and 
also demonstrated in the studies by Rawson et al. (1965), 
Vaughan et al. (1968) and Cats et a1. (1975), established 
the basis for the assay for immune complex detection, 
presented in this thesis, since the inclusions of Ig and 
C in P~-1N, reported in the above mentioned studies, probably 
represented phagocytized immune complexes. 
Therefore, a technique was developed to screen large 
numbers of PMN for the presence of Ig and c inclusions. 
At first, PMN from the blood of patients were studied 
(direct test) and later on studies of PMN from the blood 
of normal donors, after incubation with the serum to be 
tested for the presence of immune complexes (indirect test) 
were included. The isolation procedure for PMN, reported 
in chapter II, followed by freezing of the PMN-suspensions 
and subsequent cutting of 4 mu sections in a cryostat 
proved to be useful in order to obtain preparations that 
are suitable for IF-studies of these cells. The main 
advantages of this technique are that firstly a large 
number of sections can be cut from a rather small sample 
and that secondly sections can be cut at any desired moment 
after preparation of the frozen suspensions. Nuclear 
counterstaining with ethidium bromide allows easy identi-
fication of the nuclei (Udenfriend, 1969), using the same 
excitation light as for FITC fluorescence. This quick and 
simple method has proved to be very useful for determining 
the number of PMN that do not show FITC fluorescence. The 
results reported in this chapter, indicated the presence 
of Ig and C in up to 80% of the PMN isolated from 
defibrinated blood from SLE-patients. 
Since preliminary results indicated that P~1N, isolated 
from heparinized blood contained less and smaller Ig and C 
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inclusions than PMN from defibrinated blood from the same 
patients, some of the experiments described in chapter III 
were designed to investigate the influence of several 
anticoagulants and defibrination on the percentage of P!~N 
with Ig and C inclusions. These studies demonstrated a 
loss of about 20% of PMN, harvested from defibrinated 
blood, as compared to heparinized or EDTA blood. Cellular 
destruction by glass beads is most probably responsible 
for at least part of the loss, since heparinized blood 
samples which were shaken with glass beads as in the 
defibrination procedure, also showed a loss of about 20% 
of the PMN. The high percentages of PMN with Ig and C 
inclusions, as demonstrated in defibrinated samples, are 
attributed partly to in vitro phagocytosis of immune 
complexes, which resulted from the release of nuclear 
antigens, caused by cellular destruction, in the presence 
of ANA. In heparinized blood samples from SLE-patients, 
blocking of in vitro phagocytosis by the addition of MIAA 
did not result in a reduction of the number of PN.N with 
Ig and C inclusions, as compared with PMN from samples 
without MIAA. Therefore it is most likely that these 
inclusions represent in vivo phagocytosis of immune 
complexes. In this chapter, the studies of Cats et al. 
(1975) were confirmed, who reported that incubation of 
normal donor PMN with serum from SLE-patients resulted 
in phagocytosis of Ig and C (indirect test). 
Because of the possible pathogenetic role of immune 
complexes in systemic manifestations of hepatitis B 
(Gocke, 1975), in vitro studies were performed with 
artificially prepared HBsAg-anti HBs immune complexes. 
In addition, the influence of the antigen/antibody ratio 
on the in vitro phagocytosis of these complexes was tested. 
The results of these studies indicated that in PMN, 
incubated with immune complexes with an antigen/antibody 
ratio lying between 5 and 0.2, both the antigen (HBsAg) 
and antibody could be demonstrated. 
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Since it may be postulated that in human hepatitis B, 
as in experimental serum sickness, approximate balance of 
HBsAg and anti HBs r·esul ts in pathogenic immune ·complexes, 
the indirect PMN phagocytosis test should be able to 
detect potentially pathogenic HBsAg-anti HBs immune 
complexes. 
Several authors reported techniques which detected 
in up to 95% of hepatitis B patients at some stage of the 
disease the occurrence of HBsAg-containing immune complexes 
in the serum (Shulman and Barker, 1969; Prince and Trepo, 
1971; Nydegger et al., 1974; Mcintosh et al., 1976; 
Theofilopoulos et al., 1976). However, only a small 
minority of the immune complexes detected by the techniques 
used can be relevant as far as immune complex deposition, 
resulting in clinical manifest systemic disease, is con-
cerned, since the prevalence of HBsAg-associated hepatitis 
in western countries is about 1.90 per 1,000 (e.g. Szmuness 
et al., 1975) and the number of well documented cases of 
systemic disease, caused by HBsAg containing immune 
complexes published so far, is only about 45. 
Therefore, we studied the incidence of signs and 
symptoms of systemic disease, possibly related to immune 
complex deposition in patients with histologically staged 
HBsAg-associated hepatitis, as well as the occurrence of 
HBsAg in a series of renal tissue specimens. In addition, 
the PMN phagocytosis test was performed in 35 patients 
with histologically staged hepatitis B and in one patient 
with PAN. The results of these studies, reported in 
chapter V, indicate that arthralgia mainly occurs in the 
prodromal or early acute phase of hepatitis B, with an 
incidence of about 20%. This is also reported by Hosley and 
Galambos (1969) and Gocke (1975). However, histological 
and IF evidence of immune complex deposition in synovial 
tissues containing HBsAg is lacking, and no convincing 
evidence of involvement of HBsAg in the pathogenesis of 
arthralgia or arthritis has been presented in the litera-
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ture studied. The possibility of other hepatitis B 
associated antigens (e.g. hepatitis B core antigen: HBcAg) 
being responsible for the formation of pathogenic complexes 
should be considered. The appearance of anti HBc antibodies 
(anti HBc) at the beginning of clinical signs of acute 
hepatitis (Hoofnagle et al., 1973) coincides well with the 
expected sequence of serological events, if HBcAg-anti HBc 
immune complexes are responsible for skin and joint 
manifestations in the prodromal phase of acute hepatitis. 
In the material studied, 2 cases of PAN were HBsAg 
seropositive, although in one of these cases HBsAg could 
first be demonstrated in the serum 6 weeks after the timethat 
renal and skin biopsy specimens confirmed the vasculitis. 
HBsAg could not be demonstrated in renal glomeruli and 
vessel walls in the biopsy specimens in this case, using 
the IF-technique. Although in the second case of PAN it 
was also impossible to demonstrate HBsAg in the walls of 
the affected vessels, in this case no frozen tissue 
specimens were available for IF-studies. However, HBsAg 
could be demonstrated by IF in "ground glass" cells in a 
formalin fixed liver biopsy specimen from this patient, 
taken at about the same time as the skin, muscle and 
fascie biopsy specimens. 
In 8 out of 19 cases of PAN, studied by light micros-
copical and IF techniques, HBsAg has been demonstrated in 
the vessel walls in association with Ig and C (Gocke et al., 
1971; Nowoslawski et al., 1972; Heathcote et al., 1972; 
Gerber et al., 1972; Baker et al., 1972) and data from 
these studies indicate that no significant relation to 
any of the histological types of hepatitis can be recognized. 
Although the incidence of PAN in hepatitis B is very low, 
30-40% of patients with PAN are reported to be HBsAg sero-
positive (Gocke, 1975). 
Glomerulonephritis was not present in the 107 hepatitis 
B cases in our study. Neither could HBsAg be demonstrated 
in 93 cases of immune complex glomerulonephritis. 
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Therefore, the incidence of glomerulonephritis, as of PAN, 
in hepatitis B should be considered to be very low. In 
contrast to PAN however, the incidence of HBsAg in cases 
of immune complex glomerulonephritis is also very low. 
Two more differences of glomerulonephritis and PAN in their 
relation to hepatitis Bare that 1. in all cases of immune 
complex glomerulonephritis reported in association with 
hepatitis B, glomerular HBsAg-deposits have been demon-
strated by IF and/or electron microscopical examination 
(Combes et al.,1971; Nowoslawski et al., 1972; Myers et 
al., 1973; Knieser et al., 1974; Kohler et al., 1974; 
Brzoska et al., 1974; Mcintosh et al., 1976) and 2. most 
(i.e. 8 out of 10) cases of glomerulonephritis, reported 
in association with histologically typed hepatitis, 
occurred in cases of chronic active hepatitis (CAH). 
The results of the PMN phagocytosis test, applied to 
35 cases of histologically typed hepatitis B,indicated 
that immune complexes were present in the serum from 
5 out of 16 cases of CAH, and involvement of HBsAg in 
immune complex formation could be demonstrated in one of 
these cases. Only in two cases PMN inclusions were 
demonstrated unassociated with CAH, and both concerned 
cases of PAN with active vasculitis. 
Since IF studies of liver tissue have demonstrated 
the presence of HBsAg along the cellular membrane of 
hepatocytes ("diffuse pattern" according to Roos et al., 
1976} in CAH, it is conceivable that this membrane bound 
foreign antigen induces the host defence mechanism to a 
chronic breakdown of liver cells, ultimately resulting 
in fibrosis or cirrhosis. In addition, shedding of cell 
membrane bound antigen-antibody complexes may occur, and 
this is probably reflected by phagocytosis by PI'Il.N. When 
elimination of the "shedded" immune complexes is insuffi-
cient, tissue deposition in vessel walls or glomeruli 
with subsequent tissue damage may result. 
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The results of the clinicopathological studies 
reported in chapter V have demonstrated that the PMN 
phagocytosis test: 1. is able to detect immune complexes 
in sera from patients which either have manifest systemic 
disease (i.e. PAN) or are at risk to develop systemic 
disease (i.e. CAH), and 2. is able to detect the antigen 
involved in immune complex formation. Since the test can 
be performed in any laboratory equipped for IF studies, 
the technique seems to meet all three requirements 
postulated at the beginning of chapter VI. Comparative 
studies, including other immune complex detection techniques 
and further clinicopathological studies should be performed 
for evaluation of the results reported. 
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SUMMARY 
In this thesis some experimental and clinicopatholo-
gical studies are reported, which were designed with the 
purpose to develop a technique which enables to monitor 
diseases mediated by circulating immune complexes. 
In chapter I the place of immune complex mediated 
diseases among other diseases, caused by immunologic 
mechanisms resulting in tissue damage, is outlined. 
In addition, the principles of the techniques, designed 
for measurement of antigen-antibody interaction are 
summarized, as well as the fate of circulating immune 
complexes in vivo. 
In chapter II, technical details of an immunofluores-
cence procedure for PMN are discussed, since data from the 
literature indicated the occurrence of Ig and C inclusions 
in PMN, in the course of several diseases, presumably 
representing phagocytosis of immune complexes. 
In chapter III comparative studies concerning the 
influence of several anticoagulants used for Pf·1N isolation 
on the observations obtained by the IF technique are 
reported. In addition, in this chapter the influence of 
the antigen-antibody ratio on the in vitro phagocytosis of 
artificially prepared HBsAg-anti HBs immune complexes is 
demonstrated. 
Since extra hepatic manifestations of hepatitis B 
are attributed to circulating immune complexes, the 
literature concerning systemic disease and immune complex 
detection techniques used in relation to HBsAg is reviewed 
in chapter IV. 
In chapter v the incidence of signs and symptoms of 
systemic disease, possibly related to immune complex 
deposition in a series of patients with HBsAg associated 
hepatitis is reported. In addition, the occurrence of HBsAg 
in a series of cases of immune complex glomerulonephritis 
was screened, and the PMN phagocytosis test for the 
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detection of circulating immune complexes was applied to 
35 patients with HBsAg-associated hepatitis. The results of 
these studies indicate that the PMN phagocytosis test: 
1. is able to detect immune complexes in sera from patients 
who either have manifest systemic disease or are at risk 
to develop systemic disease, and 2. is able to detect the 
antigen involved in immune complex formation. 
In chapter VI 3 major requirements are postulated for an 
immune complex detection technique in order to be of 
clinical interest. Th~se requirements are: 
1. The results of the test should correlate with clinical 
signs and symptoms of immune complex mediated disease, 
i.e. the test should discriminate potentially pathogenic 
from "harmless" complexes. 
2. The test should include the possibility to detect the 
antigen involved in immune complex formation. 
3. The laboratory outfit needed should be relatively simple, 
and only commercially available reagents should be 
necessary. 
It is discussed that the results of the studies, 
reported in this thesis, indicate that the PMN phagocy-
tosis test seems to meet all these requirements. 
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SAl1ENVATTING 
De in dit proefschrift beschreven experimenten en het 
klinisch-pathologisch onderzoek werden opgezet met als 
doelstelling een techniek voor het aantonen van circuleren-
de immuuncornplexen te ontwikkelen en te toetsen. 
In hoofdstuk I worden de ziekten, veroorzaakt door 
circulerende immuuncomplexen geplaatst in het kader van die 
ziekten 1 welke veroorzaakt worden door weefselbeschadiging 
ten gevolge van een immunologische reactie. Tevens worden 
hier de principes besproken van de technieken die ontworpen 
zijn voor het rneten van antigeen-antilichaam interacties. 
Tenslotte wordt het "lot" van immuuncornplexen in de circu-
latie aangegeven. 
In hoofdstuk II wordt een immunofluorescentie proce-
dure beschreven voor uit patientenbloed geisoleerde granulo-
cyten. Deze techniek werd ontwikkeld, omdat uit literatuur-
gegevens blijkt dat in de loop van verscheidene ziekte-
beelden insluitsels in het cytoplasma van granulocyten 
kunnen voorkomen, die immunoglobulines en complement 
bevatten. Deze insluitsels vertegenwoordigen verrnoedelijk 
gephagocyteerde immuuncornplexen. 
In hoofdstuk III worden de resultaten besproken van 
enige vergelijkende onderzoekingen naar de invloed van 
verschillende anticoagulantia, gebruikt voor de isolatie 
van granulocyten uit bloedrnonsters. Bovendien wordt in dit 
hoofdstuk aangetoond dat de antigeen-antilichaarn verhouding 
van kunstmatig bereide HBsAg-anti HBs immuuncomplexen van 
invloed is op de in vitro phagocytose van deze complexen 
door granulocyten. 
Een aantal van de extrahepatische ziekteverschijnselen 
van hepatitis B wordt toegeschreven aan circulerende 
immuuncornplexen. In hoofdstuk IV wordt een overzicht 
gegeven van de literatuur die betrekking heeft op systeern 
afwijkingen en immuuncornplex detectie technieken in relatie 
met HBsAg. 
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In hoofdstuk V worden de resultaten besproken van 
drie onderzoeken: In de eerste plaatse is nagegaan wat de 
incidentie is van ziekteverschijnselen die kunnen worden 
toegeschreven aan circulerende immuuncomplexen, in een 
groep van patienten met hepatitis B met histologisch 
geklasseerde leverafwijkingen. In de tweede plaats is 
onderzocht of HBsAg kon worden aangetoond in het nierweefsel 
van een groep patienten met een glomerulonefritis op basis 
van circulerende immuuncomplexen. Ten derde worden de 
resultaten besproken van de granulocyten-phagocytosetest, 
uitgevoerd bij 35 patienten met histologisch geklasseerde 
hepatitis B. De resultaten van dit onderzoek tonen aan dat 
de granulocyten phagocytosetest: 1. in staat is immuun-
complexen aan te tonen in sera van patienten die hetzij 
manifeste systeem aandoeningen hebben, hetzij een ver-
hoogde kans hebben op het ontwikkelen van dergelijke 
aandoeningen, en 2. het antigeen dat betrokken is bij de 
vorming van irnrnuuncomplexen kan aantonen. 
In hoofdstuk VI worden 3 desiderata geformuleerd, 
waaraan een immuuncomplex detectie techniek zou moeten 
voldoen, om klinisch van betekenis te kunnen zijn. 
Deze vereisten zijn: 
1. De resultaten van de test dienen te correleren met het 
klinisch ziektebeeld, d.w.z. de test moet in staat zijn 
potentieel pathogene van onschadelijke irnmuuncornplexen 
te onderscheiden. 
2. De test moet in principe in staat zijn, ook het antigeen 
aan te tonen dat betrokken is bij de vorming van de 
circulerende irnrnuuncomplexen. 
3. Bij voorkeur dient de techniek geen kostbare en inge-
wikkelde apparatuur te vereisen, en moet deze uitgevoerd 
kunnen worden met in de handel verkrijgbare reagentia. 
De resultaten van de onderzoekingen, waarvan in dit 
proefschrift verslag wordt gedaan, wijzen er op dat de 
granulocyten phagocytosetest tegemoet lijkt te komen aan 
elk van deze vereisten. 
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